BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17:1721-1724. [PMID: 20369299 DOI: 10.1245/s10434-010-1024-1] [Cited by in Crossref: 532] [Cited by in F6Publishing: 536] [Article Influence: 44.3] [Reference Citation Analysis]
Number Citing Articles
1 Huang Q, Luo K, Yang H, Wen J, Zhang S, Li J, Ela Bella A, Liu Q, Yang F, Zheng Y, Hu R, Chen J, Fu J. Impact of alcohol consumption on survival in patients with esophageal carcinoma: a large cohort with long-term follow-up. Cancer Sci 2014;105:1638-46. [PMID: 25287715 DOI: 10.1111/cas.12552] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
2 Jiang S, Li Y, Zhu YH, Wu XQ, Tang J, Li Z, Feng GK, Deng R, Li DD, Luo RZ, Zhang MF, Qin W, Wang X, Jia WH, Zhu XF. Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma. Cancer Sci 2011;102:1568-75. [PMID: 21518141 DOI: 10.1111/j.1349-7006.2011.01964.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
3 Luna RA, Gilbert E, Hunter JG. High-grade dysplasia and intramucosal adenocarcinoma in Barrettʼs esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Current Opinion in Gastroenterology 2012;28:362-9. [DOI: 10.1097/mog.0b013e328353e346] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
4 Hanna JM, Erhunmwunsee L, Berry M, D’amico T, Onaitis M. The Prognostic Importance of the Number of Dissected Lymph Nodes After Induction Chemoradiotherapy for Esophageal Cancer. The Annals of Thoracic Surgery 2015;99:265-9. [DOI: 10.1016/j.athoracsur.2014.08.073] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
5 Liu SY, Chen W, Chughtai EA, Qiao Z, Jiang JT, Li SM, Zhang W, Zhang J. PIK3CA gene mutations in Northwest Chinese esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(14): 2585-2591 [PMID: 28465643 DOI: 10.3748/wjg.v23.i14.2585] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kong M, Shen J, Zhou C, Yang H, Chen B, Zhu C, Wang G. Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery. Ann Transl Med 2020;8:1129. [PMID: 33240978 DOI: 10.21037/atm-20-4864] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Wang F, Duan H, Cai M, Fu J, Ma G, Yang H, Tan Z, Hu R, Lin P, Zhang X. Prognostic significance of the pN classification supplemented by body mass index for esophageal squamous cell carcinoma. Thorac Cancer 2015;6:765-71. [PMID: 26557916 DOI: 10.1111/1759-7714.12259] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cai G, Li C, Yu J, Meng X. Heart Dosimetric Parameters Were Associated With Cardiac Events and Overall Survival for Patients With Locally Advanced Esophageal Cancer Receiving Definitive Radiotherapy. Front Oncol 2020;10:153. [PMID: 32226770 DOI: 10.3389/fonc.2020.00153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yagi T, Baba Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Baba H. PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer. Annals of Surgery 2019;269:471-8. [DOI: 10.1097/sla.0000000000002616] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 18.7] [Reference Citation Analysis]
10 Underwood TJ, Hayden AL, Derouet M, Garcia E, Noble F, White MJ, Thirdborough S, Mead A, Clemons N, Mellone M, Uzoho C, Primrose JN, Blaydes JP, Thomas GJ. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma. J Pathol. 2015;235:466-477. [PMID: 25345775 DOI: 10.1002/path.4467] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 15.7] [Reference Citation Analysis]
11 Xu YW, Peng YH, Chen B, Wu ZY, Wu JY, Shen JH, Zheng CP, Wang SH, Guo HP, Li EM, Xu LY. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma. Am J Gastroenterol. 2014;109:36-45. [PMID: 24296751 DOI: 10.1038/ajg.2013.384] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 7.7] [Reference Citation Analysis]
12 Wang XS, Luo KJ, Bella AE, Bu SS, Wen J, Zhang SS, Hu Y. Caspase-3 expression in metastatic lymph nodes of esophageal squamous cell carcinoma is prognostic of survival. World J Gastroenterol 2014; 20(15): 4414-4420 [PMID: 24764681 DOI: 10.3748/wjg.v20.i15.4414] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 He JZ, Wu ZY, Wang SH, Ji X, Yang CX, Xu XE, Liao LD, Wu JY, Li EM, Zhang K, Xu LY. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma. Hum Pathol 2017;66:115-25. [PMID: 28603065 DOI: 10.1016/j.humpath.2017.06.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
14 Li Q, Tanaka Y, Saitoh Y, Tanaka H, Miwa N. Carcinostatic effects of platinum nanocolloid combined with gamma irradiation on human esophageal squamous cell carcinoma. Life Sciences 2015;127:106-14. [DOI: 10.1016/j.lfs.2015.01.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wei H, Liu Z, She H, Liu B, Gu J, Wei D, Zhang X, Wang J, Qi S, Ping F. Promoter methylation and expression of Raf kinase inhibitory protein in esophageal squamous cell carcinoma. Oncol Lett 2017;13:1866-72. [PMID: 28454336 DOI: 10.3892/ol.2017.5617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Paireder M, Jomrich G, Kristo I, Asari R, Rieder E, Beer A, Ilhan-Mutlu A, Preusser M, Schmid R, Schoppmann SF. Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity. Strahlenther Onkol 2020;196:779-86. [PMID: 32055873 DOI: 10.1007/s00066-020-01594-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 Charalabopoulos A, Davakis S, Syllaios A, Lorenzi B. Intrathoracic hand-sewn esophagogastric anastomosis in prone position during totally minimally invasive two-stage esophagectomy for esophageal cancer. Dis Esophagus 2021;34:doaa106. [PMID: 33179732 DOI: 10.1093/dote/doaa106] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Chen WH, Huang YL, Chao YK, Yeh CJ, Chang HK, Tseng CK, Liu YH. Prognostic significance of lymphovascular invasion in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2015;22:338-343. [PMID: 25023545 DOI: 10.1245/s10434-014-3881-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
19 Tseng J, Posner MC. For Gastroesophageal Junction Cancers, Does an "Esophageal" or "Gastric" Surgical Approach Offer Better Perioperative and Oncologic Outcomes? Ann Surg Oncol 2020;27:511-7. [PMID: 31571057 DOI: 10.1245/s10434-019-07732-x] [Reference Citation Analysis]
20 Okada A, Ueda T. Effect of non-pharmacological intervention for apathy: response to one-on-one reminiscence-based intervention. BMJ Case Rep 2017;2017:bcr2016218898. [PMID: 28331022 DOI: 10.1136/bcr-2016-218898] [Reference Citation Analysis]
21 Xu XL, Jiang YH, Feng JG, Su D, Chen PC, Mao WM. MicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinoma. Ann Thorac Surg 2014;97:1037-45. [PMID: 24360091 DOI: 10.1016/j.athoracsur.2013.10.042] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
22 Kroese TE, Goense L, van Hillegersberg R, de Keizer B, Mook S, Ruurda JP, van Rossum PSN. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis. Dis Esophagus 2018;31. [PMID: 29917073 DOI: 10.1093/dote/doy055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
23 Guo XW, Liu YC, Gao F, Ji SJ, Zhou JY, Ji L, Zhou SB. Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma. Cancer Manag Res 2018;10:2409-18. [PMID: 30122990 DOI: 10.2147/CMAR.S167179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
24 Ma J, Xiao Y, Tian B, Chen S, Zhang B, Wu J, Wu Z, Li X, Tang J, Yang D, Zhou Y, Wang H, Su M, Wang W. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma. J Cell Biochem 2020;121:1374-87. [PMID: 31512786 DOI: 10.1002/jcb.29373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
25 Song H, Xu B, Yi J. Clinical significance of stanniocalcin-1 detected in peripheral blood and bone marrow of esophageal squamous cell carcinoma patients. J Exp Clin Cancer Res 2012;31:35. [PMID: 22537917 DOI: 10.1186/1756-9966-31-35] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
26 Dolan JP, Kaur T, Diggs BS, Luna RA, Schipper PH, Tieu BH, Sheppard BC, Hunter JG. Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer. Surg Endosc 2013;27:4094-103. [PMID: 23846365 DOI: 10.1007/s00464-013-3066-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
27 Moon DH, Jeon JH, Yang HC, Kim Y, Lee JY, Kim MS, Lee JM, Lee G. Intramural Metastasis as a Risk Factor for Recurrence in Esophageal Squamous Cell Carcinoma. The Annals of Thoracic Surgery 2018;106:249-56. [DOI: 10.1016/j.athoracsur.2018.02.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 Jung J, Park SY, Park S, Park J. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma. Tumor Biol 2016;37:7149-54. [DOI: 10.1007/s13277-015-4596-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
29 Yang H, Xu L, Qian H, Niu X, Zhao D, Zhao Z, Wu J, Liu J, Wang Y. Correlation between insulin‑like growth factor binding protein 3 and metastasis‑associated gene 1 protein in esophageal squamous cell carcinoma. Mol Med Rep 2016;13:4143-50. [PMID: 27035126 DOI: 10.3892/mmr.2016.5046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
30 Lin C, Wang L, Chou T, Hsu W, Lin H, Lee S, Lee M, Chang S, Wei Y. Cigarette Smoking and hOGG1 Ser326Cys Polymorphism are Associated with 8-OHdG Accumulation on Mitochondrial DNA in Thoracic Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2013;20:379-88. [DOI: 10.1245/s10434-012-2576-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
31 Qin RQ, Wen YS, Wang WP, Xi KX, Yu XY, Zhang LJ. The role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysis. Med Oncol. 2016;33:31. [PMID: 26922662 DOI: 10.1007/s12032-016-0746-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
32 Hagens ERC, Künzli HT, van Rijswijk A, Meijer SL, Mijnals RCD, Weusten BLAM, Geijsen ED, van Laarhoven HWM, van Berge Henegouwen MI, Gisbertz SS. Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study. Surg Endosc 2020;34:4347-57. [DOI: 10.1007/s00464-019-07205-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Ma DW, Youn YH, Jung DH, Park JJ, Kim JH, Park H. Risk factors of electrocoagulation syndrome after esophageal endoscopic submucosal dissection. World J Gastroenterol 2018; 24(10): 1144-1151 [PMID: 29563758 DOI: 10.3748/wjg.v24.i10.1144] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ren P, Chen C, Yue J, Zhang J, Yu Z. High expression of glucose-regulated protein 78 (GRP78) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2017;10:617-25. [PMID: 28228658 DOI: 10.2147/OTT.S123494] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
35 Sugawara K, Yamashita H, Okumura Y, Yagi K, Yoshimura S, Kawasaki K, Tanabe A, Aikou S, Seto Y. Relationships among body composition, muscle strength, and sarcopenia in esophageal squamous cell carcinoma patients. Support Care Cancer 2020;28:2797-803. [DOI: 10.1007/s00520-019-05110-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ma DW, Jung DH, Kim JH, Park JJ, Youn YH, Park H. Predicting lymph node metastasis for endoscopic resection of superficial esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2019; 157: 397-402. e1. [PMID: 30143376 DOI: 10.1016/j.jtcvs.2018.07.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
37 Hayes T, Smyth E, Riddell A, Allum W. Staging in Esophageal and Gastric Cancers. Hematology/Oncology Clinics of North America 2017;31:427-40. [DOI: 10.1016/j.hoc.2017.02.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
38 Duan H, Zhang X, Wang FX, Cai MY, Ma GW, Yang H, Fu JH, Tan ZH, Meng YQ, Fu XY, Ma QL, Lin P. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(18): 5591-5597 [PMID: 25987784 DOI: 10.3748/wjg.v21.i18.5591] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
39 Chao YK. Extracapsular lymph node involvement in patients with esophageal cancer treated with neoadjuvant chemoradiation therapy followed by surgery: the closer you look, the less you see. J Thorac Dis 2017;9:4270-2. [PMID: 29268488 DOI: 10.21037/jtd.2017.10.53] [Reference Citation Analysis]
40 Ludmir EB, Palta M, Zhang X, Wu Y, Willett CG, Czito BG. Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma. J Gastrointest Oncol 2014;5:401-7. [PMID: 25436117 DOI: 10.3978/j.issn.2078-6891.2014.053] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
41 Yu Y, Li Y, Lu Y, Hua X, Ma H, Li H, Wei X, Zhang J, Chen X, Liu Q, Zhu Z, Xu L, Zhang R, Sun H, Wang Z. Chin-down-plus-larynx-tightening maneuver improves choking cough after esophageal cancer surgery. Ann Transl Med 2019;7:376. [PMID: 31555690 DOI: 10.21037/atm.2019.07.08] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Goense L, Ruurda JP, Carter BW, Fang P, Ho L, Meijer GJ, van Hillegersberg R, Hofstetter WL, Lin SH. Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 2018;45:1742-51. [PMID: 29663014 DOI: 10.1007/s00259-018-4011-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
43 Nagata H, Kozaki KI, Muramatsu T, Hiramoto H, Tanimoto K, Fujiwara N, Imoto S, Ichikawa D, Otsuji E, Miyano S, Kawano T, Inazawa J. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma. Oncotarget 2017;8:37740-50. [PMID: 28465481 DOI: 10.18632/oncotarget.17147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
44 Chapman BC, Weyant M, Hilton S, Hosokawa PW, McCarter MD, Gleisner A, Nader ND, Gajdos C. Analysis of the National Cancer Database Esophageal Squamous Cell Carcinoma in the United States. Ann Thorac Surg 2019;108:1535-42. [PMID: 31302081 DOI: 10.1016/j.athoracsur.2019.05.053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
45 Sugawara K, Yamashita H, Okumura Y, Yagi K, Aikou S, Seto Y. Age-dependent survival impact of body mass index in patients with oesophageal squamous cell carcinoma. Eur J Surg Oncol 2020;46:1948-55. [PMID: 32654887 DOI: 10.1016/j.ejso.2020.05.012] [Reference Citation Analysis]
46 Das C, Shields CL. Radiotherapy for iris metastasis from esophageal carcinoma: A series of three cases. Oman J Ophthalmol 2016;9:93-6. [PMID: 27433035 DOI: 10.4103/0974-620X.184526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
47 Lin Z, Chen W, Chen Y, Peng X, Zhu K, Lin Y, Lin Q, Hu Z. A new classification of lymph node metastases according to the lymph node stations for predicting prognosis in surgical patients with esophageal squamous cell carcinoma. Oncotarget 2016;7:76261-73. [PMID: 27788489 DOI: 10.18632/oncotarget.12842] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
48 Xu F, Xu CZ, Gu J, Liu X, Liu R, Huang E, Yuan Y, Zhao G, Jiang J, Xu C, Chu Y, Lu C, Ge D. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway. Oncotarget 2016;7:43401-11. [PMID: 27270324 DOI: 10.18632/oncotarget.9726] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
49 Ueda H, Takeda M, Ueda S, Kawakami H, Okuno T, Takegawa N, Hayashi H, Tsurutani J, Tamura T, Ishikawa K, Nishimura Y, Nakagawa K. Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer. Oncotarget 2017;8:80286-94. [PMID: 29113302 DOI: 10.18632/oncotarget.17925] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
50 van den Ende T, Ter Veer E, Machiels M, Mali RMA, Abe Nijenhuis FA, de Waal L, Laarman M, Gisbertz SS, Hulshof MCCM, van Oijen MGH, van Laarhoven HWM. The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis. Cancers (Basel) 2019;11:E80. [PMID: 30641964 DOI: 10.3390/cancers11010080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
51 Künzli HT, van Berge Henegouwen MI, Gisbertz SS, van Esser S, Meijer SL, Bennink RJ, Wiezer MJ, Seldenrijk CA, Bergman JJGHM, Weusten BLAM. Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients. Dis Esophagus 2017;30:1-8. [PMID: 28881907 DOI: 10.1093/dote/dox097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
52 Huang Y, Wang H, Luo G, Zhang Y, Wang L, Li K. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma. Int J Surg 2017;38:41-7. [PMID: 28027995 DOI: 10.1016/j.ijsu.2016.12.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
53 Nobel TB, Dave N, Eljalby M, Xing X, Barbetta A, Hsu M, Tan KS, Janjigian Y, Bains MS, Sihag S, Jones DR, Molena D. Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain. Ann Thorac Surg 2020;109:329-36. [PMID: 31614136 DOI: 10.1016/j.athoracsur.2019.09.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
54 Niyaz M, Abdurahman A, Turghun A, Awut I. CEP3 and CEP17 DNA probe potential in the genetic diagnosis and prognostic prediction of esophageal squamous cell cancer. Exp Ther Med 2016;11:1375-80. [PMID: 27073452 DOI: 10.3892/etm.2016.3080] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Oshikiri T, Yasuda T, Kawasaki K, Harada H, Oyama M, Hasegawa H, Ohara T, Sendo H, Nakamura T, Fujino Y, Tominaga M, Kakeji Y. Hand-assisted laparoscopic surgery (HALS) is associated with less-restrictive ventilatory impairment and less risk for pulmonary complication than open laparotomy in thoracoscopic esophagectomy. Surgery. 2016;159:459-466. [PMID: 26361833 DOI: 10.1016/j.surg.2015.07.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
56 Rodríguez-Camacho E, Pita-Fernández S, Pértega-Díaz S, López-Calviño B, Seoane-Pillado T. Clinical-pathological characteristics and prognosis of a cohort of oesophageal cancer patients: a competing risks survival analysis. J Epidemiol 2015;25:231-8. [PMID: 25716135 DOI: 10.2188/jea.JE20140118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
57 van der Schaaf M, Johar A, Wijnhoven B, Lagergren P, Lagergren J. Extent of lymph node removal during esophageal cancer surgery and survival. J Natl Cancer Inst 2015;107:djv043. [PMID: 25748792 DOI: 10.1093/jnci/djv043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
58 Hamer PW, Hight SC, Ward IG, Harris DL, Woodham BL, Flint RS. Stricture rate after chemoradiotherapy and radiotherapy for oesophageal squamous cell carcinoma: a 20-year experience. ANZ J Surg 2019;89:367-71. [PMID: 30791194 DOI: 10.1111/ans.14981] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Zhang C, Xue G, Bi J, Geng M, Chu H, Guan Y, Wang J, Wang B. Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma. Tumour Biol 2014;35:73-80. [PMID: 23873103 DOI: 10.1007/s13277-013-1008-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
60 Park SY, Kim DJ, Suh JW, Byun GE. Comparison of the 11th Japanese classification and the AJCC 7th and 8th staging systems in esophageal squamous cell carcinoma patients. J Thorac Dis 2018;10:5039-46. [PMID: 30233878 DOI: 10.21037/jtd.2018.07.48] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
61 Donohoe CL, Phillips AW. Cancer of the esophagus and esophagogastric junction: an 8th edition staging primer. J Thorac Dis 2017;9:E282-4. [PMID: 28449521 DOI: 10.21037/jtd.2017.03.39] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
62 Neishaboori N, Wadhwa R, Nogueras-González GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG, Skinner HD, Hofstetter WL, Ajani JA. Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications. Oncology 2015;89:65-9. [PMID: 25765719 DOI: 10.1159/000371889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
63 Lin Z, Chen W, Chen Y, Peng X, Yan S, He F, Fu R, Jiang Y, Hu Z. Achieving adequate lymph node dissection in treating esophageal squamous cell carcinomas by radical lymphadenectomy: Beyond the scope of numbers of harvested lymph nodes. Oncol Lett 2019;18:1617-30. [PMID: 31423229 DOI: 10.3892/ol.2019.10465] [Reference Citation Analysis]
64 Deng H, Wang Z, Wang Y, Li G, Luo J, Chen L, Liu L, Zhou Q, Lin Y. Oesophageal adenocarcinoma has a higher risk of lymph node metastasis than squamous cell carcinoma: a propensity score-matched study. European Journal of Cardio-Thoracic Surgery 2017;52:958-62. [DOI: 10.1093/ejcts/ezx222] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
65 Machiels M, Jin P, van Hooft JE, Gurney-champion OJ, Jelvehgaran P, Geijsen ED, Jeene PM, Willemijn Kolff M, Oppedijk V, Rasch CRN, van Herk MB, Alderliesten T, Hulshof MCCM. Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers. Acta Oncologica 2019;58:943-50. [DOI: 10.1080/0284186x.2019.1588991] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
66 Kosumi K, Baba Y, Ishimoto T, Harada K, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Taki K, Higashi T, Miyata T, Kurashige J, Hiyoshi Y, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients. Surg Today 2016;46:405-13. [PMID: 26036223 DOI: 10.1007/s00595-015-1197-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
67 Kang J, Lee HP, Kim HR, Kim JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Ryu JS, Cho KJ, Lee MY, Kim SB, Kim YH, Park SR. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma. Surg Oncol 2020;35:491-7. [PMID: 33130441 DOI: 10.1016/j.suronc.2020.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Jabbour SK, Thomas CR Jr. Radiation therapy in the postoperative management of esophageal cancer. J Gastrointest Oncol 2010;1:102-11. [PMID: 22811814 DOI: 10.3978/j.issn.2078-6891.2010.013] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
69 van der Kaaij RT, Snaebjornsson P, Voncken FE, van Dieren JM, Jansen EP, Sikorska K, Cats A, van Sandick JW. The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinoma. European Journal of Cancer 2017;76:27-35. [DOI: 10.1016/j.ejca.2017.01.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
70 Findlay JM, Middleton MR, Tomlinson I. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Ann Oncol. 2015;26:624-644. [PMID: 25214541 DOI: 10.1093/annonc/mdu449] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
71 Blackham AU, H Naqvi SM, Schell MJ, Jin W, Gangi A, Almhanna K, Fontaine JP, Hoffe SE, Frakes J, Venkat P, Pimiento JM. Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer. J Surg Oncol 2018;117:150-9. [PMID: 28833197 DOI: 10.1002/jso.24808] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
72 Sobin LH, Compton CC. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 2010;116:5336-9. [PMID: 20665503 DOI: 10.1002/cncr.25537] [Cited by in Crossref: 327] [Cited by in F6Publishing: 333] [Article Influence: 29.7] [Reference Citation Analysis]
73 Brescia AA, Broderick SR, Crabtree TD, Puri V, Musick JF, Bell JM, Kreisel D, Krupnick AS, Patterson GA, Meyers BF. Adjuvant Therapy for Positive Nodes After Induction Therapy and Resection of Esophageal Cancer. Ann Thorac Surg 2016;101:200-8; discussion 208-10. [PMID: 26507424 DOI: 10.1016/j.athoracsur.2015.09.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
74 Iwagami S, Baba Y, Watanabe M, Shigaki H, Miyake K, Ida S, Nagai Y, Ishimoto T, Iwatsuki M, Sakamoto Y, Miyamoto Y, Baba H. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma. Ann Surg Oncol 2012;19:2726-32. [PMID: 22187122 DOI: 10.1245/s10434-011-2176-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
75 Hu G, Liu G, Ma JY, Hu RJ. Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis. Clin Chim Acta 2018;486:44-8. [PMID: 30028962 DOI: 10.1016/j.cca.2018.07.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
76 Chang C, Wang MJ, Bi XF, Fan ZY, Feng D, Cai HQ, Zhang Y, Xu X, Cai Y, Qi J, Wei WQ, Hao JJ, Wang MR. Elevated serum eotaxin and IP-10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma. J Clin Lab Anal 2021;35:e23904. [PMID: 34288108 DOI: 10.1002/jcla.23904] [Reference Citation Analysis]
77 Toxopeus E, van der Schaaf M, van Lanschot J, Lagergren J, Lagergren P, van der Gaast A, Wijnhoven B. Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS). Ann Surg Oncol. 2018;25:2441-2448. [PMID: 29948420 DOI: 10.1245/s10434-018-6554-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
78 Baba Y, Yoshida N, Kinoshita K, Iwatsuki M, Yamashita YI, Chikamoto A, Watanabe M, Baba H. Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study. Ann Surg 2018;267:478-83. [PMID: 28151796 DOI: 10.1097/SLA.0000000000002118] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
79 Zhang Y, Li C, Chen M. Prognostic value of immunohistochemical factors in esophageal small cell carcinoma (ESCC): analysis of clinicopathologic features of 73 patients. J Thorac Dis 2018;10:4023-31. [PMID: 30174845 DOI: 10.21037/jtd.2018.06.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
80 van Olphen SH, Biermann K, Shapiro J, Wijnhoven BPL, Toxopeus ELA, van der Gaast A, Stoop HA, van Lanschot JJB, Spaander MCW, Bruno MJ, Looijenga LHJ. P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy. Annals of Surgery 2017;265:347-55. [DOI: 10.1097/sla.0000000000001625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
81 Gu WS, Fang WZ, Liu CY, Pan KY, Ding R, Li XH, Duan CH. Prognostic significance of combined pretreatment body mass index (BMI) and BMI loss in patients with esophageal cancer. Cancer Manag Res 2019;11:3029-41. [PMID: 31114349 DOI: 10.2147/CMAR.S197820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
82 Zhang L, Hu S, Korteweg C, Chen Z, Qiu Y, Su M, Gu J. Expression of immunoglobulin G in esophageal squamous cell carcinomas and its association with tumor grade and Ki67. Hum Pathol 2012;43:423-34. [PMID: 21855109 DOI: 10.1016/j.humpath.2011.05.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
83 Zhang SS, Yang H, Luo KJ, Huang QY, Chen JY, Yang F, Cai XL, Xie X, Liu QW, Bella AE, Hu RG, Wen J, Hu Y, Fu JH. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer. 2013;109:2894-2903. [PMID: 24201750 DOI: 10.1038/bjc.2013.666] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
84 Anakotta RM, van der Laan HP, Visser S, Ribeiro CO, Dieters M, Langendijk JA, Both S, Korevaar EW, Sijtsema NM, Knopf A, Muijs CT. Weekly robustness evaluation of intensity-modulated proton therapy for oesophageal cancer. Radiotherapy and Oncology 2020;151:66-72. [DOI: 10.1016/j.radonc.2020.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
85 Lee HN, Kim JI, Shin SY, Kim DH, Kim C, Hong IK. Combined CT texture analysis and nodal axial ratio for detection of nodal metastasis in esophageal cancer. Br J Radiol 2020;93:20190827. [PMID: 32242741 DOI: 10.1259/bjr.20190827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
86 Guo X, Zhou J, Jiang W, Ji L, Liu Y, Yin X. The Combination of Preoperative Nutritional Risk Screening-2002 and Neutrophil-to-Lymphocyte Ratio is a Useful Prognostic Marker in Patients with Esophageal Squamous Cell Carcinoma. Nutrition and Cancer 2021;73:588-95. [DOI: 10.1080/01635581.2020.1766090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Jung HK, Tae CH, Lee HA, Lee H, Don Choi K, Park JC, Kwon JG, Choi YJ, Hong SJ, Sung J, Chung WC, Kim KB, Kim SY, Song KH, Park KS, Jeon SW, Kim BW, Ryu HS, Lee OJ, Baik GH, Kim YS, Jung HY; Korean College of Helicobacter and Upper Gastrointestinal Research. Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients. PLoS One 2020;15:e0231456. [PMID: 32275699 DOI: 10.1371/journal.pone.0231456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
88 Sugawara K, Yagi K, Uemura Y, Okumura Y, Nishida M, Aikou S, Yamashita H, Seto Y. Associations of Systemic Inflammation and Sarcopenia With Survival of Esophageal Carcinoma Patients. Ann Thorac Surg 2020;110:374-82. [PMID: 32278754 DOI: 10.1016/j.athoracsur.2020.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Best LM, Mughal M, Gurusamy KS. Non-surgical versus surgical treatment for oesophageal cancer. Cochrane Database Syst Rev 2016;3:CD011498. [PMID: 27021481 DOI: 10.1002/14651858.CD011498.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
90 Mazer LM, Poultsides GA. What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer? Surg Clin North Am 2019;99:457-69. [PMID: 31047035 DOI: 10.1016/j.suc.2019.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
91 Gao A, Wang L, Li J, Li H, Han Y, Ma X, Sun Y. Prognostic Value of Perineural Invasion in Esophageal and Esophagogastric Junction Carcinoma: A Meta-Analysis. Dis Markers 2016;2016:7340180. [PMID: 27051075 DOI: 10.1155/2016/7340180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
92 Zhu Y, Li M, Bo C, Liu X, Zhang J, Li Z, Zhao F, Kong L, Yu J. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma. Cancer Immunol Immunother 2017;66:343-54. [PMID: 27915370 DOI: 10.1007/s00262-016-1931-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
93 Kauppi J, Räsänen J, Sihvo E, Huuhtanen R, Nelskylä K, Salo J. Open versus minimally invasive esophagectomy: clinical outcomes for locally advanced esophageal adenocarcinoma. Surg Endosc 2015;29:2614-9. [PMID: 25480610 DOI: 10.1007/s00464-014-3978-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
94 Nobel TB, Curry M, Gennarelli R, Jones DR, Molena D. Higher clinical suspicion is needed for prompt diagnosis of esophageal adenocarcinoma in young patients. J Thorac Cardiovasc Surg 2019:S0022-5223(19)30796-2. [PMID: 31126651 DOI: 10.1016/j.jtcvs.2019.03.095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Raymond DP, Seder CW, Wright CD, Magee MJ, Kosinski AS, Cassivi SD, Grogan EL, Blackmon SH, Allen MS, Park BJ, Burfeind WR, Chang AC, DeCamp MM, Wormuth DW, Fernandez FG, Kozower BD. Predictors of Major Morbidity or Mortality After Resection for Esophageal Cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database Risk Adjustment Model. Ann Thorac Surg 2016;102:207-14. [PMID: 27240449 DOI: 10.1016/j.athoracsur.2016.04.055] [Cited by in Crossref: 119] [Cited by in F6Publishing: 107] [Article Influence: 19.8] [Reference Citation Analysis]
96 Zanoni A, Verlato G, Baiocchi GL, Casella F, Cossu A, d'Ignazio A, De Pascale S, Giacopuzzi S. Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us? Updates Surg 2018;70:241-9. [PMID: 29808375 DOI: 10.1007/s13304-018-0537-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
97 Zhu JF, Feng XY, Zhang XW, Wen YS, Lin P, Cai L, Zhang LJ. Time distribution of recurrence risk of oesophageal squamous cell carcinoma with complete resection (R0) in a Chinese population. Eur J Cardiothorac Surg 2015;48:899-905. [PMID: 25899517 DOI: 10.1093/ejcts/ezv147] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Ai D, Chen Y, Liu Q, Deng J, Zhao K. The effect of tumor locations of esophageal cancer on the metastasis to liver or lung. J Thorac Dis 2019;11:4205-10. [PMID: 31737304 DOI: 10.21037/jtd.2019.09.67] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Lehman HL, Yang X, Welsh PA, Stairs DB. p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma. Am J Pathol 2015;185:240-51. [PMID: 25529795 DOI: 10.1016/j.ajpath.2014.09.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
100 Chiang XH, Hsu HH, Hsieh MS, Chang CH, Tsai TM, Liao HC, Tsou KC, Lin MW, Chen JS. Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma. Ann Surg Oncol 2020;27:703-15. [PMID: 31646453 DOI: 10.1245/s10434-019-07974-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
101 Ma X, Li B, Yang S, Guo W, Zhu X, Li H, Xiang J, Zhang Y, Chen H. Extent of lymph node dissection: common hepatic artery lymph node dissection can be omitted for esophageal squamous cell carcinoma. J Thorac Dis 2014;6 Suppl 3:S325-32. [PMID: 24876938 DOI: 10.3978/j.issn.2072-1439.2014.04.33] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
102 Lemini R, Díaz Vico T, Trumbull DA, Attwood K, Spaulding AC, Elli EF, Colibaseanu DT, Kukar M, Gabriel E. Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators. J Gastrointest Oncol 2021;12:1963-72. [PMID: 34790364 DOI: 10.21037/jgo-20-337] [Reference Citation Analysis]
103 Peng J, Wang W, Yuan Y, Hu Y, Wang Y, Chen L. Optimal Extent of Lymph Node Dissection for Siewert Type II Esophagogastric Junction Adenocarcinoma. The Annals of Thoracic Surgery 2015;100:263-9. [DOI: 10.1016/j.athoracsur.2015.02.075] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
104 Lehman HL, Kidacki M, Warrick JI, Stairs DB. NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation. Oncotarget 2018;9:11180-96. [PMID: 29541406 DOI: 10.18632/oncotarget.24358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
105 Lam AK. Application of Pathological Staging in Esophageal Squamous Cell Carcinoma. Methods Mol Biol 2020;2129:19-31. [PMID: 32056167 DOI: 10.1007/978-1-0716-0377-2_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
106 Song BG, Min YW, Lee JH, Lee H, Min B, Rhee P, Kim JJ. Efficacy and safety of endoscopic submucosal dissection in elderly patients with esophageal squamous cell carcinoma. Surg Endosc 2017;31:3905-11. [DOI: 10.1007/s00464-017-5421-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
107 Mo J, Chen D, Li C, Chen M. The Significance of Negative Lymph Nodes in Esophageal Cancer After Curative Resection: A Retrospective Cohort Study. Cancer Manag Res 2020;12:1269-79. [PMID: 32110101 DOI: 10.2147/CMAR.S232856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
108 Blackham AU, Yue B, Almhanna K, Saeed N, Fontaine JP, Hoffe S, Shridhar R, Frakes J, Coppola D, Pimiento JM. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response: ypT0N+ Esophageal Cancer. J Surg Oncol 2015;112:597-602. [DOI: 10.1002/jso.24050] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
109 Takahashi M, Yoshimura S, Takyu S, Aikou S, Okumura Y, Yagi K, Fukayama M, Momose T, Seto Y, Yamaya T. A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients. Ann Nucl Med 2021. [PMID: 34843102 DOI: 10.1007/s12149-021-01701-9] [Reference Citation Analysis]
110 Balasubramanian S, Chittawadagi B, Misra S, Ramakrishnan P, Chinnusamy P. Propensity matched analysis of short term oncological and perioperative outcomes following robotic and thoracolaparoscopic esophagectomy for carcinoma esophagus- the first Indian experience. J Robot Surg 2021. [PMID: 33609251 DOI: 10.1007/s11701-021-01211-w] [Reference Citation Analysis]
111 Oshikiri T, Yasuda T, Harada H, Goto H, Oyama M, Hasegawa H, Ohara T, Sendo H, Nakamura T, Fujino Y, Tominaga M, Kakeji Y. A new method (the "Bascule method") for lymphadenectomy along the left recurrent laryngeal nerve during prone esophagectomy for esophageal cancer. Surg Endosc 2015;29:2442-50. [PMID: 25303923 DOI: 10.1007/s00464-014-3919-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
112 Li Y, Yang HX, Luo RZ, Zhang Y, Li M, Wang X, Jia WH. High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma. Ann Thorac Surg 2011;91:1531-8. [PMID: 21524463 DOI: 10.1016/j.athoracsur.2010.12.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
113 Ng T. For esophageal cancer, biology is still king. J Thorac Cardiovasc Surg 2016;152:761-2. [PMID: 27325491 DOI: 10.1016/j.jtcvs.2016.05.045] [Reference Citation Analysis]
114 Zhang F, Cheng F, Cao L, Wang S, Zhou W, Ma W. A retrospective study: the prevalence and prognostic value of anemia in patients undergoing radiotherapy for esophageal squamous cell carcinoma. World J Surg Oncol 2014;12:244. [PMID: 25085112 DOI: 10.1186/1477-7819-12-244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
115 Hollis AC, Quinn LM, Hodson J, Evans E, Plowright J, Begum R, Mitchell H, Hallissey MT, Whiting JL, Griffiths EA. Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer. J Surg Oncol 2017;116:1114-22. [PMID: 28767142 DOI: 10.1002/jso.24789] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
116 Lin CS, Liu CY, Cheng CT, Tsai YC, Chiou LW, Lee MY, Liu CC, Shih CH. Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy. J Thorac Dis 2017;9:3193-207. [PMID: 29221296 DOI: 10.21037/jtd.2017.08.108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
117 Schieman C, Wigle DA, Deschamps C, Nichols FC, Cassivi SD, Shen KR, Allen MS. Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy. The Annals of Thoracic Surgery 2013;95:459-63. [DOI: 10.1016/j.athoracsur.2012.10.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
118 Li Y, Yu H, Luo RZ, Zhang Y, Zhang MF, Wang X, Jia WH. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma. J Surg Oncol. 2011;104:617-622. [PMID: 21744352 DOI: 10.1002/jso.22018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
119 Zhang HD, Tang P, Duan XF, Chen CG, Ma Z, Gao YY, Zhang H, Yu ZT. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction. J Surg Oncol 2013;108:542-9. [PMID: 24018956 DOI: 10.1002/jso.23430] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
120 Zhao X, Ren Y, Hu Y, Cui N, Wang X, Cui Y. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials. PLoS One 2018;13:e0202185. [PMID: 30138325 DOI: 10.1371/journal.pone.0202185] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
121 Söderström HK, Kauppi JT, Oksala N, Paavonen T, Krogerus L, Räsänen J, Rantanen T. Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma. World J Clin Cases 2019; 7(3): 260-269 [PMID: 30746368 DOI: 10.12998/wjcc.v7.i3.260] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
122 Sylvie L, Silvia S, Salah-eddin A, Markus F, Florian L, Peter T, Bernhard H, Martin A, Alexander N. Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancer. European Journal of Cancer 2015;51:1918-26. [DOI: 10.1016/j.ejca.2015.07.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
123 Jin P, Hulshof MC, de Jong R, van Hooft JE, Bel A, Alderliesten T. Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography. Radiotherapy and Oncology 2016;118:492-7. [DOI: 10.1016/j.radonc.2016.01.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
124 Meng YQ, Cao X, Wen ZS, Liu QW, Tan ZH, Duan H, Ma GW, Lin P. Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma: SAA versus CRP in esophageal cancer. Dis Esophagus 2014;27:670-7. [DOI: 10.1111/dote.12128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
125 Qin B, Dong M, Wang Z, Wan J, Xie Y, Jiao Y, Yan D. Long non‑coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO‑mediated demethylation. Oncol Rep 2021;45:1059-71. [PMID: 33650646 DOI: 10.3892/or.2020.7917] [Reference Citation Analysis]
126 Huang Z, Li S, Yang X, Lu F, Huang M, Zhang S, Xiong Y, Zhang P, Si J, Ma Y, Yang Y. Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study. Cancer Manag Res 2019;11:1299-308. [PMID: 30799956 DOI: 10.2147/CMAR.S195355] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
127 Li K, Wang Y, Liu X, Wang R, Jiang Y, Guo W. Propensity-Matched Analysis Comparing Survival After Hybrid Thoracoscopic–Laparotomy Esophagectomy and Complete Thoracoscopic–Laparoscopic Esophagectomy. World J Surg 2019;43:853-61. [DOI: 10.1007/s00268-018-4843-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
128 Saddoughi SA, Mitchell KG, Antonoff MB, Fruth KM, Taswell J, Mounajjed T, Hofstetter WWL, Rice DC, Shen KR, Blackmon SH. Analysis of Esophagectomy Margin Practice and Survival Implications. Ann Thorac Surg 2021:S0003-4975(21)00143-0. [PMID: 33524359 DOI: 10.1016/j.athoracsur.2021.01.028] [Reference Citation Analysis]
129 Schizas D, Kapsampelis P, Mylonas KS MD. Adenosquamous Carcinoma of the Esophagus: A Literature Review. J Transl Int Med. 2018;6:70-73. [PMID: 29984200 DOI: 10.2478/jtim-2018-0014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
130 Toxopeus ELA, Nieboer D, Shapiro J, Biermann K, van der Gaast A, van Rij CM, Steyerberg EW, van Lanschot JJB, Wijnhoven BPL. Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer. Radiotherapy and Oncology 2015;115:392-8. [DOI: 10.1016/j.radonc.2015.04.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
131 Hoffmann L, Poulsen PR, Ravkilde T, Bertholet J, Kruhlikava I, Helbo BL, Schmidt ML, Nordsmark M. Setup strategies and uncertainties in esophageal radiotherapy based on detailed intra- and interfractional tumor motion mapping. Radiotherapy and Oncology 2019;136:161-8. [DOI: 10.1016/j.radonc.2019.04.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
132 Li L, Liu M, Lin JB, Hong XB, Chen WX, Guo H, Xu LY, Xu YW, Li EM, Peng YH. Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma. Dis Markers. 2017;2017:2534648. [PMID: 28298808 DOI: 10.1155/2017/2534648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
133 Angelescu C, Burada F, Ioana M, Angelescu R, Moraru E, Riza A, Marchian S, Mixich F, Cruce M, Săftoiu A. VEGF-A and VEGF-B mRNA expression in gastro-oesophageal cancers. Clin Transl Oncol 2013;15:313-20. [PMID: 22872519 DOI: 10.1007/s12094-012-0923-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
134 Saigí M, Oliva M, Aliste L, Calvo M, Hormigo G, Serra Ò, Boladeras A, Farran L, Robles J, Creus G, Paúles MJ, Gornals JB, de Lama E, Borràs JM, Sala N, Galán M. Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre. PLoS One 2017;12:e0184737. [PMID: 28931046 DOI: 10.1371/journal.pone.0184737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
135 Gupta V, Levy J, Allen-Ayodabo C, Amirazodi E, Davis L, Li Q, Mahar A, Coburn NG; PRESTO Study Investigators. Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO): protocol for a multicentre clinical and pathological database including 25 000 patients. BMJ Open 2020;10:e032729. [PMID: 32474423 DOI: 10.1136/bmjopen-2019-032729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
136 Yao YW, He YF, Han XH, Ji CS, Hu B. Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype. Oncol Lett 2018;16:2539-48. [PMID: 30013648 DOI: 10.3892/ol.2018.8894] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
137 Beukinga RJ, Wang D, Karrenbeld A, Dijksterhuis WPM, Faber H, Burgerhof JGM, Mul VEM, Slart RHJA, Coppes RP, Plukker JTM. Addition of HER2 and CD44 to 18F-FDG PET-based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer. Eur Radiol 2021;31:3306-14. [PMID: 33151397 DOI: 10.1007/s00330-020-07439-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
138 Wu J, Chen QX, Zhou XM, Mao WM, Krasna MJ, Teng LS. Prognostic significance of solitary lymph node metastasis in patients with squamous cell carcinoma of middle thoracic esophagus. World J Surg Oncol 2012;10:210. [PMID: 23036154 DOI: 10.1186/1477-7819-10-210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
139 Davies AR, Zylstra J, Baker CR, Gossage JA, Dellaportas D, Lagergren J, Findlay JM, Puccetti F, El Lakis M, Drummond RJ, Dutta S, Mera A, Van Hemelrijck M, Forshaw MJ, Maynard ND, Allum WH, Low D, Mason RC. A comparison of the left thoracoabdominal and Ivor–Lewis esophagectomy. Diseases of the Esophagus 2018;31:dox129. [DOI: 10.1093/dote/dox129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
140 Zhang J, Chen J, Ma T, Guo H, Yang B. Genetic variants of FOXP1 and FOXF1 are associated with the susceptibility of oesophageal adenocarcinoma in Chinese population. J Genet 2018;97:213-8. [DOI: 10.1007/s12041-018-0910-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Squires MH, Gower N, Benbow JH, Donahue EE, Bohl CE, Prabhu RS, Hill JS, Salo JC. PET Imaging and Rate of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 34625880 DOI: 10.1245/s10434-021-10644-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Sadot E, Kraus S, Stein M, Naboishchikov I, Toledano O, Kazanov D, Arber N, Kashtan H. CD24 gene polymorphism--a novel prognostic factor in esophageal cancer. Int J Biol Markers. 2014;29:e49-e54. [PMID: 24474454 DOI: 10.5301/jbm.5000071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
143 Toxopeus E, Lynam-Lennon N, Biermann K, Dickens G, de Ruiter PE, van Lanschot J, Reynolds JV, Wijnhoven B, O'Sullivan J, van der Laan L. Tumor microRNA-126 controls cell viability and associates with poor survival in patients with esophageal adenocarcinoma. Exp Biol Med (Maywood) 2019;244:1210-9. [PMID: 31390899 DOI: 10.1177/1535370219868671] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
144 Wang L, Wang C, Wang J, Huang X, Cheng Y. Longitudinal, observational study on associations between postoperative nutritional vitamin D supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. Sci Rep. 2016;6:38962. [PMID: 27958342 DOI: 10.1038/srep38962] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
145 Tang A, Sohal D, McNamara M, Murthy SC, Raja S. Siewert III Adenocarcinoma: Still Searching for the Right Treatment Combination. Surg Oncol Clin N Am 2020;29:647-53. [PMID: 32883464 DOI: 10.1016/j.soc.2020.07.002] [Reference Citation Analysis]
146 Shi H, Ma S, Zhao P, Jiang J, Cheng Y, Zhao J, Wang J, Qiao Z, Jiang J, Li S, Wu J. Endoscopic ultrasonography for preoperative staging of esophageal carcinoma. Scand J Gastroenterol 2017;52:1052-6. [PMID: 28625089 DOI: 10.1080/00365521.2017.1339829] [Reference Citation Analysis]
147 Zhao Y, Guo J, You B, Hou S, Hu B, Li H. The dynamic of nasogastric decompression after esophagectomy and its predictive value of postoperative complications. J Thorac Dis 2016;8:S99-S106. [PMID: 26941977 DOI: 10.3978/j.issn.2072-1439.2015.10.72] [Reference Citation Analysis]
148 Wang Q, Wu Z, Zhan T, Fang S, Zhang S, Shen G, Wu M. Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis. BMC Cancer 2019;19:500. [PMID: 31132995 DOI: 10.1186/s12885-019-5656-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
149 Park SY, Kim DJ, Do YW, Suh J, Lee S. The Oncologic Outcome of Esophageal Squamous Cell Carcinoma Patients After Robot-Assisted Thoracoscopic Esophagectomy With Total Mediastinal Lymphadenectomy. The Annals of Thoracic Surgery 2017;103:1151-7. [DOI: 10.1016/j.athoracsur.2016.09.037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
150 Wojcieszynski AP, Berman AT, Wan F, Plastaras JP, Metz JM, Mitra N, Apisarnthanarax S. The impact of radiation therapy sequencing on survival and cardiopulmonary mortality in the combined modality treatment of patients with esophageal cancer: RT Sequencing in Esophageal Cancer. Cancer 2013;119:1976-84. [DOI: 10.1002/cncr.27970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
151 Rizk N. Gastroesophageal Junction Tumors. Ann Surg Oncol 2016;23:3798-800. [DOI: 10.1245/s10434-016-5427-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
152 Zhou L, Baba Y, Kitano Y, Miyake K, Zhang X, Yamamura K, Kosumi K, Kaida T, Arima K, Taki K, Higashi T, Imai K, Hashimoto D, Yamashita Y, Chikamoto A, Beppu T, Tan X, Baba H. KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review. Med Oncol 2016;33. [DOI: 10.1007/s12032-016-0745-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
153 Khanna LG, Gress FG. Preoperative evaluation of oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29:179-191. [PMID: 25743465 DOI: 10.1016/j.bpg.2014.12.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
154 Palmes D, Brüwer M, Bader FG, Betzler M, Becker H, Bruch HP, Büchler M, Buhr H, Ghadimi BM, Hopt UT, Konopke R, Ott K, Post S, Ritz JP, Ronellenfitsch U, Saeger HD, Senninger N; German Advanced Surgical Treatment Study Group. Diagnostic evaluation, surgical technique, and perioperative management after esophagectomy: consensus statement of the German Advanced Surgical Treatment Study Group. Langenbecks Arch Surg 2011;396:857-66. [PMID: 21713594 DOI: 10.1007/s00423-011-0818-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
155 Li X, Zhao L, Zhang W, Yang C, Lian Z, Wang S, Liu N, Pang Q, Wang P, Yu J. Prognostic value of supraclavicular nodes and upper abdominal nodes metastasis after definitive chemoradiotherapy for patients with thoracic esophageal squamous cell carcinoma. Oncotarget 2017;8:65171-85. [PMID: 29029421 DOI: 10.18632/oncotarget.18015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
156 Song WA, Fan BS, Di SY, Liu JQ, Zhao JH, Chen SY, Yue CY, Zhou SH, Gong TQ. Three-Field Lymphadenectomy in Minimally Invasive Esophagectomy for Squamous Cell Carcinoma. Ann Thorac Surg 2021;112:928-34. [PMID: 33152329 DOI: 10.1016/j.athoracsur.2020.09.022] [Reference Citation Analysis]
157 Paul S, Altorki N. Outcomes in the management of esophageal cancer. J Surg Oncol. 2014;110:599-610. [PMID: 25146593 DOI: 10.1002/jso.23759] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
158 He FC, Meng WW, Qu YH, Zhou MX, He J, Lv P, Ming L. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(15): 4660-4665 [PMID: 25914476 DOI: 10.3748/wjg.v21.i15.4660] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
159 Noji T, Miyamoto M, Kubota KC, Shinohara T, Ambo Y, Matsuno Y, Kashimura N, Hirano S. Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol 2012;10:106. [PMID: 22681770 DOI: 10.1186/1477-7819-10-106] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
160 Lu S, Hsu F, Tsai C, Wu J, Lee J, Huang P, Hsu C, Koong AC, Chang DT, Chia-hsien Cheng J. Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiation Therapy Is Associated With Postoperative Pulmonary Complications in Esophageal Cancer Patients Undergoing Combined Modality Therapy. International Journal of Radiation Oncology*Biology*Physics 2015;93:1023-31. [DOI: 10.1016/j.ijrobp.2015.08.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
161 Xu YW, Liu CT, Huang XY, Huang LS, Luo YH, Hong CQ, Guo HP, Xu LY, Peng YH, Li EM. Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma. Dis Markers. 2017;2017:5384091. [PMID: 28852266 DOI: 10.1155/2017/5384091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
162 Ahmed ME, Mahadi SI, Ali BM. The surgical treatment of esophageal cancer in Sudan: A 100 consecutive cases. Int J Surg. 2016;29:101-107. [PMID: 26987513 DOI: 10.1016/j.ijsu.2016.03.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
163 Ruan R, Chen S, Tao Y, Yu J, Zhou D, Cui Z, Shen Q, Wang S. Retrospective analysis of predictive factors for lymph node metastasis in superficial esophageal squamous cell carcinoma. Sci Rep 2021;11:16544. [PMID: 34400710 DOI: 10.1038/s41598-021-96088-y] [Reference Citation Analysis]
164 Liu X, Li M, Zhao F, Zhu Y, Luo Y, Kong L, Zhu H, Zhang Y, Shi F, Yu J. The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy. Onco Targets Ther 2017;10:871-7. [PMID: 28243122 DOI: 10.2147/OTT.S124915] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
165 Zhu CM, Ling YH, Xi SY, Luo RZ, Chen JW, Yun JP, Xie D, Cai MY. Prognostic significance of the pN classification supplemented by vascular invasion for esophageal squamous cell carcinoma. PLoS One 2014;9:e96129. [PMID: 24763284 DOI: 10.1371/journal.pone.0096129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
166 Anderegg MCJ, Ruurda JP, Gisbertz SS, Blom RLGM, Sosef MN, Wijnhoven BPL, Hulshof MCCM, Bergman JJGHM, van Laarhoven HWM, van Berge Henegouwen MI. Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma. Eur J Surg Oncol 2020;46:626-31. [PMID: 31706717 DOI: 10.1016/j.ejso.2019.10.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Akutsu Y, Matsubara H. The significance of lymph node status as a prognostic factor for esophageal cancer. Surg Today. 2011;41:1190-1195. [PMID: 21874413 DOI: 10.1007/s00595-011-4542-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
168 Li XH, Gu WS, Wang XP, Lin JH, Zheng X, Zhang L, Kang T, Zhang ZX, Liu WL. Low Preoperative albumin-to-globulin ratio Predict Poor Survival and Negatively Correlated with Fibrinogen in Resectable Esophageal Squamous Cell Carcinoma. J Cancer 2017;8:1833-42. [PMID: 28819381 DOI: 10.7150/jca.19062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
169 Fathinul Fikri AS, Dharmendran R, Vikneswaran P, Nordin AJ. 18F-FDG PET/CT as a potential predictor of survival in patient with oesophageal cancer: a preliminary result. Abdom Imaging 2015;40:1457-64. [DOI: 10.1007/s00261-014-0343-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
170 Xi Y, Ma Z, Shen Y, Wang H, Feng M, Tan L, Wang Q. A novel method for lymphadenectomy along the left laryngeal recurrent nerve during thoracoscopic esophagectomy for esophageal carcinoma. J Thorac Dis 2016;8:24-30. [PMID: 26904208 DOI: 10.3978/j.issn.2072-1439.2016.01.11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
171 Baba Y, Watanabe M, Shigaki H, Iwagami S, Ishimoto T, Iwatsuki M, Baba H. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma. Surgery 2013;153:234-41. [DOI: 10.1016/j.surg.2012.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
172 Chung TR, Kim JH, Lee IJ, Cho Y, Kim JW, Lee CG, Jung DH, Park JJ, Youn YH, Park H. Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement. Dig Liver Dis 2019;51:1610-6. [PMID: 31175014 DOI: 10.1016/j.dld.2019.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
173 Song H, Fang F, Valdimarsdóttir U, Lu D, Andersson TM, Hultman C, Ye W, Lundell L, Johansson J, Nilsson M, Lindblad M. Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study. BMC Cancer 2017;17:2. [PMID: 28049452 DOI: 10.1186/s12885-016-3013-7] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
174 Wu AJ, Bosch WR, Chang DT, Hong TS, Jabbour SK, Kleinberg LR, Mamon HJ, Thomas CR Jr, Goodman KA. Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. Int J Radiat Oncol Biol Phys 2015;92:911-20. [PMID: 26104943 DOI: 10.1016/j.ijrobp.2015.03.030] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
175 Smit JK, Faber H, Niemantsverdriet M, Baanstra M, Bussink J, Hollema H, van Os RP, Plukker JT, Coppes RP. Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers. Radiother Oncol. 2013;107:434-441. [PMID: 23684587 DOI: 10.1016/j.radonc.2013.03.027] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
176 Wu S, Zhou J, Ren Y, Sun J, Li F, Lin Q, Lin H, He Z. Tumor location is a prognostic factor for survival of Chinese women with T1-2N0M0 breast cancer. Int J Surg 2014;12:394-8. [PMID: 24657350 DOI: 10.1016/j.ijsu.2014.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
177 Liu W, Xie L, He YH, Wu ZY, Liu LX, Bai XF, Deng DX, Xu XE, Liao LD, Lin W, Heng JH, Xu X, Peng L, Huang QF, Li CY, Zhang ZD, Wang W, Zhang GR, Gao X, Wang SH, Li CQ, Xu LY, Liu W, Li EM. Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting. Nat Commun 2021;12:4961. [PMID: 34400640 DOI: 10.1038/s41467-021-25202-5] [Reference Citation Analysis]
178 Asadi-Lari M, Homaee-Shandiz F, Esmaeili-Hesari A. Changes in health-related quality of life in oesophagogastric cancer patients participating in palliative and curative therapies. Med J Islam Repub Iran 2018;32:31. [PMID: 30159282 DOI: 10.14196/mjiri.32.31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
179 Kleinberg L, Brock M, Gibson M. Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus. Curr Treat Options Oncol 2015;16:35. [PMID: 26112428 DOI: 10.1007/s11864-015-0352-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
180 Li R, Leng AM, Liu XM, Hu TZ, Zhang LF, Li M, Jiang XX, Zhou YW, Xu CX. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma. Tumour Biol 2017;39:1010428317705013. [PMID: 28651486 DOI: 10.1177/1010428317705013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
181 Mu JW, Gao SG, Xue Q, Mao YS, Wang DL, Zhao J, Gao YS, Huang JF, He J. The impact of operative approaches on outcomes of middle and lower third esophageal squamous cell carcinoma. J Thorac Dis 2016;8:3588-95. [PMID: 28149553 DOI: 10.21037/jtd.2016.12.42] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
182 Nakajo M, Jinguji M, Nakabeppu Y, Nakajo M, Higashi R, Fukukura Y, Sasaki K, Uchikado Y, Natsugoe S, Yoshiura T. Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy. Eur J Nucl Med Mol Imaging 2017;44:206-14. [PMID: 27613542 DOI: 10.1007/s00259-016-3506-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
183 Huang Q, Luo K, Chen C, Wang G, Jin J, Kong M, Li B, Liu Q, Li J, Rong T. Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma. J Thorac Oncol. 2016;11:583-592. [PMID: 26792626 DOI: 10.1016/j.jtho.2015.12.109] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
184 Lu C, Xu F, Gu J, Yuan Y, Zhao G, Yu X, Ge D. Clinical and biological significance of stem-like CD133+CXCR4+ cells in esophageal squamous cell carcinoma. The Journal of Thoracic and Cardiovascular Surgery 2015;150:386-95. [DOI: 10.1016/j.jtcvs.2015.05.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
185 Sancheti M, Fernandez F. Management of T2 esophageal cancer. Surg Clin North Am. 2012;92:1169-1178. [PMID: 23026276 DOI: 10.1016/j.suc.2012.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
186 Kuo S, Chen J, Huang P, Hsu H, Lai H, Lee J. Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2014;148:1200-1207.e3. [DOI: 10.1016/j.jtcvs.2014.04.038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
187 Park SY, Yoon JK, Lee SJ, Haam S, Jung J. Prognostic value of preoperative total psoas muscle area on long-term outcome in surgically treated oesophageal cancer patients. Interact Cardiovasc Thorac Surg 2017;24:13-9. [PMID: 27587471 DOI: 10.1093/icvts/ivw274] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
188 Yang Y, Jia J, Sun Z, Liu C, Xiao Y, Yu J, Du F, Zhang X. Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:2177-84. [PMID: 32273757 DOI: 10.2147/CMAR.S242780] [Reference Citation Analysis]
189 Manoharan V, Lee S, Chong S, Yap J, Coupe N, Wilson R, Merrett N, Ng W, Lin M. Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy. Ann Nucl Med 2017;31:315-23. [PMID: 28299585 DOI: 10.1007/s12149-017-1159-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
190 Chen B, Deng M, Yang C, Dragomir MP, Zhao L, Bai K, Xi M, Hu Y, Zhu Y, Li Q. High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis. Radiother Oncol 2021;158:191-9. [PMID: 33667583 DOI: 10.1016/j.radonc.2021.02.031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
191 Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JA. Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma. Oncology 2015;88:332-6. [PMID: 25765098 DOI: 10.1159/000368611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
192 Marzola MC, De Manzoni G, Grassetto G, Cordiano C, Al-nahhas A, Alavi A, Rubello D. Extended staging of oesophageal cancer using FDG-PET – A critical appraisal. European Journal of Radiology 2012;81:21-30. [DOI: 10.1016/j.ejrad.2010.10.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
193 D'Annoville T, D'Journo XB, Loundou A, Trousse D, Dahan L, Doddoli C, Seitz JF, Thomas PA. Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System. Eur J Cardiothorac Surg 2013;44:e207-11; discussion e211. [PMID: 23818566 DOI: 10.1093/ejcts/ezt332] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
194 Wang K, Zhong J, Liu Q, Lin P, Fu J. A Propensity Score-Matched Analysis of Thoracolaparoscopic vs Open McKeown's Esophagectomy. Ann Thorac Surg 2021:S0003-4975(21)00307-6. [PMID: 33621558 DOI: 10.1016/j.athoracsur.2021.02.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Xu YW, Peng YH, Ran LQ, Zhai TT, Guo HP, Qiu SQ, Chen HL, Wu ZY, Li EM, Xie JJ. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma. Clin Transl Oncol. 2017;19:898-906. [PMID: 28181176 DOI: 10.1007/s12094-017-1623-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
196 Kim D, Cho J, Kim K, Shim YM. Chyle leakage patterns and management after oncologic esophagectomy: A retrospective cohort study. Thorac Cancer 2014;5:391-7. [PMID: 26767030 DOI: 10.1111/1759-7714.12105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
197 Blum AE, Venkitachalam S, Ravillah D, Chelluboyina AK, Kieber-Emmons AM, Ravi L, Kresak A, Chandar AK, Markowitz SD, Canto MI, Wang JS, Shaheen NJ, Guo Y, Shyr Y, Willis JE, Chak A, Varadan V, Guda K. Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer. Gastroenterology 2019;156:1761-74. [PMID: 30768984 DOI: 10.1053/j.gastro.2019.01.263] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
198 Haisley KR, Hart CM, Kaempf AJ, Dash NR, Dolan JP, Hunter JG. Specific Tumor Characteristics Predict Upstaging in Early-Stage Esophageal Cancer. Ann Surg Oncol 2019;26:514-22. [PMID: 30377918 DOI: 10.1245/s10434-018-6804-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
199 Zhang SS, Lei YY, Cai XL, Yang H, Xia X, Luo KJ, Su CH, Zou JY, Zeng B, Hu Y. Preoperative serum fibrinogen is an independent prognostic factor in operable esophageal cancer. Oncotarget. 2016;7:25461-25469. [PMID: 27009857 DOI: 10.18632/oncotarget.8171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
200 Goense L, Visser E, Haj Mohammad N, Mook S, Verhoeven RHA, Meijer GJ, van Rossum PSN, Ruurda JP, van Hillegersberg R. Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: A population-based cohort study. Eur J Surg Oncol 2018;44:620-5. [PMID: 29478739 DOI: 10.1016/j.ejso.2018.02.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
201 Park SY, Suh JW, Kim DJ, Park JC, Kim EH, Lee CY, Lee JG, Paik HC, Chung KY. Near-Infrared Lymphatic Mapping of the Recurrent Laryngeal Nerve Nodes in T1 Esophageal Cancer. Ann Thorac Surg 2018;105:1613-20. [PMID: 29518388 DOI: 10.1016/j.athoracsur.2018.01.083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
202 Guo W, Zou YB, Ma Z, Niu HJ, Jiang YG, Zhao YP, Gong TQ, Wang RW. One surgeon’s learning curve for video-assisted thoracoscopic esophagectomy for esophageal cancer with the patient in lateral position: how many cases are needed to reach competence? Surg Endosc. 2013;27:1346-1352. [PMID: 23093242 DOI: 10.1007/s00464-012-2614-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
203 Nakamura K, Yoshida N, Baba Y, Kosumi K, Uchihara T, Kiyozumi Y, Ohuchi M, Ishimoto T, Iwatsuki M, Sakamoto Y, Watanabe M, Baba H. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer. Int J Clin Oncol 2017;22:469-75. [PMID: 28097441 DOI: 10.1007/s10147-017-1090-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
204 Buergy D, Lohr F, Baack T, Siebenlist K, Haneder S, Michaely H, Wenz F, Boda-Heggemann J. Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy. Radiat Oncol. 2012;7:192. [PMID: 23157945 DOI: 10.1186/1748-717x-7-192] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
205 Zhang H, Shang X, Ren P, Gong L, Ahmed A, Ma Z, Ma R, Wu X, Xiao X, Jiang H, Tang P, Yu Z. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. J Cell Physiol 2019;234:1794-802. [PMID: 30070689 DOI: 10.1002/jcp.27052] [Cited by in Crossref: 30] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
206 Wang BY, Huang JY, Chen HC, Lin CH, Lin SH, Hung WH, Cheng YF. The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients. J Cancer Res Clin Oncol 2020;146:43-52. [PMID: 31705294 DOI: 10.1007/s00432-019-03079-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
207 Shim YM, Park JS, Lee M, Kim D, Kim K. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?: Can common hepatic artery lymph node dissection be omitted in surgery for T1N0 esophageal cancer? Dis Esophagus 2013;26:272-5. [DOI: 10.1111/j.1442-2050.2012.01361.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
208 Park SY, Kim DJ, Suh JW, Byun GE. Risk Factors for Weight Loss 1 Year After Esophagectomy and Gastric Pull-up for Esophageal Cancer. J Gastrointest Surg 2018;22:1137-43. [PMID: 29611091 DOI: 10.1007/s11605-018-3749-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
209 Di Pardo BJ, Bronson NW, Diggs BS, Thomas CR Jr, Hunter JG, Dolan JP. The Global Burden of Esophageal Cancer: A Disability-Adjusted Life-Year Approach. World J Surg 2016;40:395-401. [PMID: 26630937 DOI: 10.1007/s00268-015-3356-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
210 Cai G, Yu J, Meng X. Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy. Cancer Manag Res 2020;12:8497-507. [PMID: 33061564 DOI: 10.2147/CMAR.S257058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
211 Davies AR, Gossage JA, Zylstra J, Mattsson F, Lagergren J, Maisey N, Smyth EC, Cunningham D, Allum WH, Mason RC. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol. 2014;32:2983-2990. [PMID: 25071104 DOI: 10.1200/jco.2014.55.9070] [Cited by in Crossref: 129] [Cited by in F6Publishing: 70] [Article Influence: 18.4] [Reference Citation Analysis]
212 Yun JS, Na KJ, Song SY, Kim S, Jeong IS, Oh SG. Comparison of perioperative outcomes following hybrid minimally invasive versus open Ivor Lewis esophagectomy for esophageal cancer. J Thorac Dis. 2017;9:3097-3104. [PMID: 29221284 DOI: 10.21037/jtd.2017.08.49] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
213 van Nistelrooij AM, Andrinopoulou ER, van Lanschot JJ, Tilanus HW, Wijnhoven BP. Influence of young age on outcome after esophagectomy for cancer. World J Surg 2012;36:2612-21. [PMID: 22814593 DOI: 10.1007/s00268-012-1718-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
214 Moura RN, Arantes VN, Ribeiro TML, Guimarães RG, de Oliveira JF, Kulcsar MAV, Sallum RAA, Ribeiro-Junior U, Maluf-Filho F. Does a history of head and neck cancer affect outcome of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma? Endosc Int Open 2020;8:E900-10. [PMID: 32617394 DOI: 10.1055/a-1147-8977] [Reference Citation Analysis]
215 Yu CW, Chen XJ, Lin YH, Tseng YH, Lu CC, Chen BB, Wei SY, Lee JM, Shih TT. Prognostic value of 18F-FDG PET/MR imaging biomarkers in oesophageal squamous cell carcinoma. Eur J Radiol 2019;120:108671. [PMID: 31629121 DOI: 10.1016/j.ejrad.2019.108671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
216 Dinh HQ, Pan F, Wang G, Huang QF, Olingy CE, Wu ZY, Wang SH, Xu X, Xu XE, He JZ, Yang Q, Orsulic S, Haro M, Li LY, Huang GW, Breunig JJ, Koeffler HP, Hedrick CC, Xu LY, Lin DC, Li EM. Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment. Nat Commun 2021;12:7335. [PMID: 34921160 DOI: 10.1038/s41467-021-27599-5] [Reference Citation Analysis]
217 Yang Y, Zhang X, Li B, Hua R, Yang Y, He Y, Ye B, Guo X, Sun Y, Li Z. Short- and mid-term outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study. Dis Esophagus 2020;33:doz080. [PMID: 31608939 DOI: 10.1093/dote/doz080] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 19.0] [Reference Citation Analysis]
218 Harada G, Bonadio RRDCC, de Araújo FCC, Victor CR, Sallum RAA, Junior UR, Cecconello I, Takeda FR, de Castria TB. Induction Chemotherapy for Locally Advanced Esophageal Cancer.J Gastrointest Cancer. 2020;51:498-505. [PMID: 31240598 DOI: 10.1007/s12029-019-00266-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
219 Ozcan HEA, Anuk T, Ozden O. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma. Adv Med Sci 2018;63:296-300. [PMID: 29803118 DOI: 10.1016/j.advms.2018.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
220 Wang X, Kong Y, Chi Z, Sheng X, Cui C, Mao L, Lian B, Tang B, Yan X, Si L, Guo J. Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients. Thorac Cancer. 2019;10:950-956. [PMID: 30864295 DOI: 10.1111/1759-7714.13034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
221 Baba Y, Yagi T, Kosumi K, Okadome K, Nomoto D, Eto K, Hiyoshi Y, Nagai Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Komohara Y, Watanabe M, Baba H. Morphological lymphocytic reaction, patient prognosis and PD-1 expression after surgical resection for oesophageal cancer. Br J Surg 2019;106:1352-61. [PMID: 31414718 DOI: 10.1002/bjs.11301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
222 Nobel TB, Livschitz J, Xing XX, Barbetta A, Hsu M, Tan KS, Sihag S, Jones DR, Molena D. Surveillance Implications of Recurrence Patterns in Early Node-Negative Esophageal Adenocarcinoma. Ann Thorac Surg 2019;108:1640-7. [PMID: 31323215 DOI: 10.1016/j.athoracsur.2019.05.066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
223 de Nucci G, Petrone MC, Imperatore N, Asti E, Rossi G, Manes G, Vecchi M, Pastorelli L, Bonavina L, Arcidiacono PG. Staging esophageal cancer: low EUS accuracy in t2n0 patients. Endosc Int Open 2021;9:E313-8. [PMID: 33655027 DOI: 10.1055/a-1336-2505] [Reference Citation Analysis]
224 Guo K, Cai L, Zhang Y, Zhu JF, Rong TH, Lin P, Hao CL, Wang WP, Li Z, Zhang LJ. The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy. Chin J Cancer. 2012;31:399-408. [PMID: 22572013 DOI: 10.5732/cjc.011.10406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
225 Voncken FE, Nakhaee S, Stam B, Wiersema L, Vollenbrock SE, van Dieren JM, van Leerdam ME, Sonke J, Aleman BM, Remeijer P. Quantification of Esophageal Tumor Motion and Investigation of Different Image-Guided Correction Strategies. Practical Radiation Oncology 2020;10:84-92. [DOI: 10.1016/j.prro.2019.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
226 Nga WTB, Eloumou SAFB, Engbang JPN, Bell EMD, Mayeh AMM, Atenguena E, Biwole ME, Ayissi GBN, Kenfack G, Noah DN, Luma HN, Sone AM, Ndom P, Ndam ECN. [Prognosis and survival of esophageal cancer in Cameroon: a prognostic study]. Pan Afr Med J 2019;33:73. [PMID: 31448035 DOI: 10.11604/pamj.2019.33.73.16112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
227 Matsumoto H, Okamoto Y, Kawai A, Ueno D, Kubota H, Murakami H, Higashida M, Hirai T. Prognosis Prediction for Postoperative Esophageal Cancer Patients Using Onodera's Prognostic Nutritional Index. Nutrition and Cancer 2017;69:849-54. [DOI: 10.1080/01635581.2017.1339093] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
228 Long H, Yang H, Lin Y, Situ D, Liu W. Fish Oil-Supplemented Parenteral Nutrition in Patients Following Esophageal Cancer Surgery: Effect on Inflammation and Immune Function. Nutrition and Cancer 2013;65:71-5. [DOI: 10.1080/01635581.2013.741761] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
229 Khan N, Donohoe CL, Phillips AW, Griffin SM, Reynolds JV. Signet ring gastric and esophageal adenocarcinomas: characteristics and prognostic implications. Dis Esophagus 2020;33:doaa016. [PMID: 32378712 DOI: 10.1093/dote/doaa016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
230 Oshikiri T, Yasuda T, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Sumi Y, Nakamura T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y. Short-term outcomes and one surgeon’s learning curve for thoracoscopic esophagectomy performed with the patient in the prone position. Surg Today 2017;47:313-9. [DOI: 10.1007/s00595-016-1378-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
231 Zhang Z, Wen P, Li F, Yao C, Wang T, Liang B, Yang Q, Ma L, He L. HIPK2 inhibits cell metastasis and improves chemosensitivity in esophageal squamous cell carcinoma. Exp Ther Med 2018;15:1113-8. [PMID: 29434701 DOI: 10.3892/etm.2017.5468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
232 Zhu Y, Li M, Mu D, Kong L, Zhang J, Zhao F, Li Z, Liu X, Bo C, Yu J. CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer. Oncotarget 2016;7:71455-65. [PMID: 27683115 DOI: 10.18632/oncotarget.12213] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
233 Fox MP, van Berkel V. Management of gastroesophageal junction tumors. Surg Clin North Am. 2012;92:1199-1212. [PMID: 23026278 DOI: 10.1016/j.suc.2012.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
234 Nobel TB, Sihag S, Xing XX, Eljalby M, Hsu M, Tan KS, Sewell DB, Bains MS, Janjigian Y, Wu A, Ku G, Jones DR, Molena D. Oligometastases After Curative Esophagectomy Are Not One-Size-Fits-All. Ann Thorac Surg 2021:S0003-4975(21)00454-9. [PMID: 33689743 DOI: 10.1016/j.athoracsur.2021.03.002] [Reference Citation Analysis]
235 Cancer Genome Atlas Research Network., Analysis Working Group: Asan University., BC Cancer Agency., Brigham and Women’s Hospital., Broad Institute., Brown University., Case Western Reserve University., Dana-Farber Cancer Institute., Duke University., Greater Poland Cancer Centre., Harvard Medical School., Institute for Systems Biology., KU Leuven., Mayo Clinic., Memorial Sloan Kettering Cancer Center., National Cancer Institute., Nationwide Children’s Hospital., Stanford University., University of Alabama., University of Michigan., University of North Carolina., University of Pittsburgh., University of Rochester., University of Southern California., University of Texas MD Anderson Cancer Center., University of Washington., Van Andel Research Institute., Vanderbilt University., Washington University., Genome Sequencing Center: Broad Institute., Washington University in St. Louis., Genome Characterization Centers: BC Cancer Agency., Broad Institute., Harvard Medical School., Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University., University of North Carolina., University of Southern California Epigenome Center., University of Texas MD Anderson Cancer Center., Van Andel Research Institute., Genome Data Analysis Centers: Broad Institute., Brown University:., Harvard Medical School., Institute for Systems Biology., Memorial Sloan Kettering Cancer Center., University of California Santa Cruz., University of Texas MD Anderson Cancer Center., Biospecimen Core Resource: International Genomics Consortium., Research Institute at Nationwide Children’s Hospital., Tissue Source Sites: Analytic Biologic Services., Asan Medical Center., Asterand Bioscience., Barretos Cancer Hospital., BioreclamationIVT., Botkin Municipal Clinic., Chonnam National University Medical School., Christiana Care Health System., Cureline., Duke University., Emory University., Erasmus University., Indiana University School of Medicine., Institute of Oncology of Moldova., International Genomics Consortium., Invidumed., Israelitisches Krankenhaus Hamburg., Keimyung University School of Medicine., Memorial Sloan Kettering Cancer Center., National Cancer Center Goyang., Ontario Tumour Bank., Peter MacCallum Cancer Centre., Pusan National University Medical School., Ribeirão Preto Medical School., St. Joseph’s Hospital &Medical Center., St. Petersburg Academic University., Tayside Tissue Bank., University of Dundee., University of Kansas Medical Center., University of Michigan., University of North Carolina at Chapel Hill., University of Pittsburgh School of Medicine., University of Texas MD Anderson Cancer Center., Disease Working Group: Duke University., Memorial Sloan Kettering Cancer Center., National Cancer Institute., University of Texas MD Anderson Cancer Center., Yonsei University College of Medicine., Data Coordination Center: CSRA Inc., Project Team: National Institutes of Health. Integrated genomic characterization of oesophageal carcinoma. Nature 2017;541:169-75. [PMID: 28052061 DOI: 10.1038/nature20805] [Cited by in Crossref: 798] [Cited by in F6Publishing: 676] [Article Influence: 159.6] [Reference Citation Analysis]
236 Li Q, Wu SG, Gao JM, Xu JJ, Hu LY, Xu T. Impact of esophageal cancer staging on overall survival and disease-free survival based on the 2010 AJCC classification by lymph nodes. J Radiat Res. 2013;54:307-314. [PMID: 23124992 DOI: 10.1093/jrr/rrs096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
237 Rao X, Huang D, Sui X, Liu G, Song X, Xie J, Huang D. Overexpression of WRAP53 is associated with development and progression of esophageal squamous cell carcinoma. PLoS One 2014;9:e91670. [PMID: 24626331 DOI: 10.1371/journal.pone.0091670] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
238 Vollenbrock SE, van Dieren JM, Voncken FEM, van Turenhout ST, Kodach LL, Hartemink KJ, van Sandick JW, Aleman BMP, Beets-Tan RGH, Bartels-Rutten A. Added value of MRI to endoscopic and endosonographic response assessment after neoadjuvant chemoradiotherapy in oesophageal cancer. Eur Radiol 2020;30:2425-34. [PMID: 31965258 DOI: 10.1007/s00330-019-06605-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Rawicz-Pruszyński K, van Sandick JW, Mielko J, Ciseł B, Polkowski WP. Current challenges in gastric cancer surgery: European perspective. Surg Oncol 2018;27:650-6. [PMID: 30449488 DOI: 10.1016/j.suronc.2018.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
240 Semenkovich TR, Panni RZ, Hudson JL, Thomas T, Elmore LC, Chang SH, Meyers BF, Kozower BD, Puri V. Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis. J Thorac Cardiovasc Surg 2018;155:2221-2230.e1. [PMID: 29428700 DOI: 10.1016/j.jtcvs.2018.01.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
241 Xie X, Luo K, Hu Y, Wang J, Chen J. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer: Preoperative PLR and ESCC outcomes. Dis Esophagus 2016;29:79-85. [DOI: 10.1111/dote.12296] [Cited by in Crossref: 40] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
242 Zhang P, Xi M, Zhao L, Li QQ, He L, Liu S, Shen J, Liu MZ. Unilateral cervical nodal metastasis is an independent prognostic factor for esophageal squamous cell carcinoma patients undergoing chemoradiotherapy: a retrospective study. PLoS One 2014;9:e101332. [PMID: 24979040 DOI: 10.1371/journal.pone.0101332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
243 Goense L, van Rossum PSN, Xi M, Maru DM, Carter BW, Meijer GJ, Ho L, van Hillegersberg R, Hofstetter WL, Lin SH. Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma. Ann Surg Oncol 2018;25:1598-607. [PMID: 29569125 DOI: 10.1245/s10434-018-6435-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
244 Yu X, Yang J, Chen T, Liu Y, Xue W, Wang M, Bai S. Excessive Pretreatment Weight Loss Is a Risk Factor for the Survival Outcome of Esophageal Carcinoma Patients Undergoing Radical Surgery and Postoperative Adjuvant Chemotherapy. Canadian Journal of Gastroenterology and Hepatology 2018;2018:1-8. [DOI: 10.1155/2018/6075207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
245 Fan M, Lin Y, Pan J, Yan W, Dai L, Shen L, Chen K. Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. Thorac Cancer. 2016;7:173-181. [PMID: 27042219 DOI: 10.1111/1759-7714.12299] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
246 Zhang F, Han H, Wang C, Wang J, Zhang G, Cao F, Cheng Y. A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy. World J Surg Oncol 2013;11:249. [PMID: 24083572 DOI: 10.1186/1477-7819-11-249] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
247 Toxopeus ELA, de Man FM, Krak N, Biermann K, Nieuweboer AJM, Friberg LE, Oomen-de Hoop E, van Lanschot JJB, Shapiro J, Wijnhoven BPL, Mathijssen RHJ. Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer. Cancers (Basel) 2019;11:E173. [PMID: 30717316 DOI: 10.3390/cancers11020173] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
248 Ye P, Cao JL, Li QY, Wang ZT, Yang YH, Lv W, Hu J. Mediastinal transposition of the omentum reduces infection severity and pharmacy cost for patients undergoing esophagectomy. J Thorac Dis 2016;8:1653-60. [PMID: 27499954 DOI: 10.21037/jtd.2016.05.92] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
249 Luo K, Wen J, Xie X, Fu J, Luo R, Wu Q, Hu Y. Prognostic Relevance of Id-1 Expression in Patients With Resectable Esophageal Squamous Cell Carcinoma. The Annals of Thoracic Surgery 2012;93:1682-8. [DOI: 10.1016/j.athoracsur.2012.01.102] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
250 Hong SJ, Kim TJ, Nam KB, Lee IS, Yang HC, Cho S, Kim K, Jheon S, Lee KW. New TNM staging system for esophageal cancer: what chest radiologists need to know. Radiographics 2014;34:1722-40. [PMID: 25310426 DOI: 10.1148/rg.346130079] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
251 Heneghan HM, Donohoe C, Elliot J, Ahmed Z, Malik V, Ravi N, Reynolds JV. Can CT-PET and Endoscopic Assessment Post-Neoadjuvant Chemoradiotherapy Predict Residual Disease in Esophageal Cancer? Annals of Surgery 2016;264:831-8. [DOI: 10.1097/sla.0000000000001902] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
252 Kjaer DW, Larsson H, Svendsen LB, Jensen LS. Changes in treatment and outcome of oesophageal cancer in Denmark between 2004 and 2013. British Journal of Surgery 2017;104:1338-45. [DOI: 10.1002/bjs.10586] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
253 Huang Q, Fang C, Shi J, Sun Q, Wu H, Gold JS, Weber HC, Guan W, Zhang Y, Yu C. Differences in Clinicopathology of Early Gastric Carcinoma between Proximal and Distal Location in 438 Chinese Patients. Sci Rep. 2015;5:13439. [PMID: 26310451 DOI: 10.1038/srep13439] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
254 Wei R, Dong W, Shen H, Ni Y, Zhang T, Wang Y, Du J. Predictive Effects of Lung function test on Postoperative Pneumonia in Squamous Esophageal Cancer. Sci Rep 2016;6:23636. [PMID: 27004739 DOI: 10.1038/srep23636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
255 Gurusamy KS, Pallari E, Midya S, Mughal M. Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer. Cochrane Database Syst Rev 2016;3:CD011390. [PMID: 27030301 DOI: 10.1002/14651858.CD011390.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
256 Zhang SS, Xie X, Wen J, Luo KJ, Liu QW, Yang H, Hu Y, Fu JH. TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma. Diagn Pathol 2016;11:14. [PMID: 26818094 DOI: 10.1186/s13000-016-0457-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
257 Hu SJ, Zhao XK, Song X, Lei LL, Han WL, Xu RH, Wang R, Zhou FY, Wang L, Wang LD. Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma. World J Gastroenterol 2021; 27(4): 321-335 [PMID: 33584065 DOI: 10.3748/wjg.v27.i4.321] [Reference Citation Analysis]
258 Jones CM, Spencer K, Hitchen C, Pelly T, Wood B, Hatfield P, Crellin A, Sebag-Montefiore D, Goody R, Crosby T, Radhakrishna G. Hypofractionated Radiotherapy in Oesophageal Cancer for Patients Unfit for Systemic Therapy: A Retrospective Single-Centre Analysis. Clin Oncol (R Coll Radiol) 2019;31:356-64. [PMID: 30737068 DOI: 10.1016/j.clon.2019.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
259 Sugawara K, Yagi K, Okumura Y, Aikou S, Yamashita H, Seto Y. Survival Prediction Capabilities of Preoperative Inflammatory and Nutritional Status in Esophageal Squamous Cell Carcinoma Patients. World J Surg 2022. [PMID: 34999904 DOI: 10.1007/s00268-021-06398-5] [Reference Citation Analysis]
260 Peng J, Wang WP, Yuan Y, Wang ZQ, Wang Y, Chen LQ. Adequate lymphadenectomy in patients with oesophageal squamous cell carcinoma: resecting the minimal number of lymph node stations. Eur J Cardiothorac Surg 2016;49:e141-6. [PMID: 26905182 DOI: 10.1093/ejcts/ezw015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
261 Lutkenhaus LJ, Kamphuis M, van Wieringen N, Hulshof MC, Bel A. Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer. Radiotherapy and Oncology 2013;109:200-3. [DOI: 10.1016/j.radonc.2013.09.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
262 Davies AR, Pillai A, Sinha P, Sandhu H, Adeniran A, Mattsson F, Choudhury A, Forshaw MJ, Gossage JA, Lagergren J, Allum WH, Mason RC. Factors associated with early recurrence and death after esophagectomy for cancer: Early Recurrence After Esophagectomy. J Surg Oncol 2014;109:459-64. [DOI: 10.1002/jso.23511] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
263 Fukui T, Taniguchi T, Kawaguchi K, Fukumoto K, Nakamura S, Sakao Y, Yokoi K. Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma. Gen Thorac Cardiovasc Surg 2015;63:507-13. [DOI: 10.1007/s11748-015-0564-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
264 Takeno S, Takahashi Y, Hashimoto T, Maki K, Shibata R, Yamana I, Sasaki T, Yoshida Y, Shiwaku H, Yamashita K, Aisu N, Yamashita Y, Moroga T, Ono K, Kawahara K. Is the prognostic impact of tumor location in patients with surgically resected esophageal squamous cell carcinoma affected by surgical approach? Eur Surg Res 2013;51:91-8. [PMID: 24157453 DOI: 10.1159/000355680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
265 McNamara MJ, Adelstein DJ. Current developments in the management of locally advanced esophageal cancer. Curr Oncol Rep. 2012;14:342-349. [PMID: 22544559 DOI: 10.1007/s11912-012-0239-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
266 Zanoni A. Nodal downstaging in esophageal and esophagogastric junction cancer: more important than ever. J Thorac Dis 2017;9:1839-42. [PMID: 28839979 DOI: 10.21037/jtd.2017.06.126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
267 Yang H, Wei J, Xu Y, Liu J, Lin P, Rong T, Fu J. Modification of Nodal Categories in the Seventh American Joint Committee on Cancer Staging System for Esophageal Squamous Cell Carcinoma in Chinese Patients. The Annals of Thoracic Surgery 2011;92:216-24. [DOI: 10.1016/j.athoracsur.2011.03.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
268 Jeon J, Lee J, Moon D, Yang H, Kim M, Lee G, Zo J. Prognostic significance of venous invasion and maximum standardized uptake value of 18F-FDG PET/CT in surgically resected T1N0 esophageal squamous cell carcinoma. European Journal of Surgical Oncology (EJSO) 2017;43:471-7. [DOI: 10.1016/j.ejso.2016.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
269 Zhang SS, Wen J, Yang F, Cai XL, Yang H, Luo KJ, Liu QW, Hu RG, Xie X, Huang QY, Chen JY, Fu JH, Hu Y. High expression of transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Med Oncol. 2013;30:607. [PMID: 23686700 DOI: 10.1007/s12032-013-0607-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
270 Xing X, Gao Y, Wang H, Qu S, Huang C, Zhang H, Wang H, Sun K. Correlation of fluid balance and postoperative pulmonary complications in patients after esophagectomy for cancer. J Thorac Dis 2015;7:1986-93. [PMID: 26716037 DOI: 10.3978/j.issn.2072-1439.2015.11.24] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
271 Fox M, Farmer R, Scoggins CR, Mcmasters KM, Martin RCG. Lymph Node Ratio is a Significant Predictor of Disease-Specific Mortality in Patients Undergoing Esophagectomy for Cancer. The American Surgeon 2012;78:528-34. [DOI: 10.1177/000313481207800532] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
272 Ji WH, Jiang YH, Ji YL, Li B, Mao WM. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy. Dis Esophagus 2016;29:403-11. [PMID: 25625421 DOI: 10.1111/dote.12322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
273 Honda M, Sakamoto T, Kojima S, Yamamoto Y, Yajima K, Kim DH, Ogawa F. Aortoenteric fistula following overlap esophagojejunal anastomosis using linear staplers for cancer of the esophagogastric junction: a case report. Surg Case Rep 2019;5:9. [PMID: 30649632 DOI: 10.1186/s40792-019-0566-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
274 Wu XN, Liu CQ, Tian JY, Guo MF, Xu MQ. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma. Int J Surg. 2017;41:6-11. [PMID: 28323156 DOI: 10.1016/j.ijsu.2017.03.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
275 Xing XZ, Wang HJ, Qu SN, Huang CL, Zhang H, Wang H, Yang QH, Gao Y. The value of esophagectomy surgical apgar score (eSAS) in predicting the risk of major morbidity after open esophagectomy. J Thorac Dis 2016;8:1780-7. [PMID: 27499969 DOI: 10.21037/jtd.2016.06.28] [Cited by in Crossref: 43] [Cited by in F6Publishing: 21] [Article Influence: 7.2] [Reference Citation Analysis]
276 Zhang Y, He S, Dou L, Liu Y, Ke Y, Yu X, Wang Z, Wang G. Esophageal cancer N staging study with endoscopic ultrasonography. Oncol Lett 2019;17:863-70. [PMID: 30655840 DOI: 10.3892/ol.2018.9716] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
277 Wani S, Wallace MB, Cohen J, Pike IM, Adler DG, Kochman ML, Lieb JG, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Tokar JL. Quality Indicators for EUS. American Journal of Gastroenterology 2015;110:102-13. [DOI: 10.1038/ajg.2014.387] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
278 Li S, Su J, Sui Q, Wang G. A nomogram for predicting postoperative pulmonary infection in esophageal cancer patients. BMC Pulm Med 2021;21:283. [PMID: 34488717 DOI: 10.1186/s12890-021-01656-7] [Reference Citation Analysis]
279 Ni PZ, Yang YS, Hu WP, Wang WP, Yuan Y, Chen LQ. Primary adenosquamous carcinoma of the esophagus: an analysis of 39 cases. J Thorac Dis. 2016;8:2689-2696. [PMID: 27867543 DOI: 10.21037/jtd.2016.09.59] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
280 King R, Hayes C, Donohoe CL, Dunne MR, Davern M, Donlon NE. Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers. World J Gastrointest Oncol 2021; 13(5): 312-331 [PMID: 34040696 DOI: 10.4251/wjgo.v13.i5.312] [Reference Citation Analysis]
281 Jin P, van der Horst A, de Jong R, van Hooft JE, Kamphuis M, van Wieringen N, Machiels M, Bel A, Hulshof MC, Alderliesten T. Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer. Radiother Oncol 2015;117:412-8. [PMID: 26475250 DOI: 10.1016/j.radonc.2015.10.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
282 Li W, Li Y, Huang Q, Ye S, Rong T. Short and Long-Term Outcomes of Epidural or Intravenous Analgesia after Esophagectomy: A Propensity-Matched Cohort Study. PLoS One 2016;11:e0154380. [PMID: 27110939 DOI: 10.1371/journal.pone.0154380] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
283 Manabe O, Hattori N, Hirata K, Itoh K, Hosokawa M, Takahashi H, Oyama-Manabe N, Tamaki N. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer. J Nucl Med 2013;54:670-6. [PMID: 23516310 DOI: 10.2967/jnumed.112.110304] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
284 Hou X, Liang RB, Wei JC, Xu Y, Fu JH, Luo RZ, He JH, Zhang LJ, Lin P, Yang HX. Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma. Oncotarget 2016;7:31088-96. [PMID: 27145270 DOI: 10.18632/oncotarget.9078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
285 Wen Q, Yang Z, Zhu J, Qiu Q, Dai H, Feng A, Xing L. Pretreatment CT-Based Radiomics Signature as a Potential Imaging Biomarker for Predicting the Expression of PD-L1 and CD8+TILs in ESCC. Onco Targets Ther. 2020;13:12003-12013. [PMID: 33244242 DOI: 10.2147/ott.s261068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
286 Kawase A, Yoshida J, Ishii G, Nakao M, Aokage K, Hishida T, Nishimura M, Nagai K. Differences Between Squamous Cell Carcinoma and Adenocarcinoma of the Lung: Are Adenocarcinoma and Squamous Cell Carcinoma Prognostically Equal? Japanese Journal of Clinical Oncology 2012;42:189-95. [DOI: 10.1093/jjco/hyr188] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
287 Chen Y, Lue K, Chu S, Chang B, Wang L, Liu D, Liu S, Chao Y, Chan S. Combining the radiomic features and traditional parameters of 18F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery. Ann Nucl Med 2019;33:657-70. [DOI: 10.1007/s12149-019-01380-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
288 Park SY, Kim DJ, Jung HS, Yun MJ, Lee JW, Park CK. Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma. World J Surg 2015;39:2948-54. [PMID: 26324159 DOI: 10.1007/s00268-015-3221-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
289 Hou X, Wei JC, Fu JH, Wang X, Luo RZ, He JH, Zhang LJ, Lin P, Yang HX. Vascular Endothelial Growth Factor is a Useful Predictor of Postoperative Distant Metastasis and Survival Prognosis in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2015;22:3666-73. [PMID: 25652047 DOI: 10.1245/s10434-015-4390-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
290 van Nistelrooij AM, van Steenbergen LN, Spaander MC, Tilanus HW, van Lanschot JJ, Lemmens VE, Wijnhoven BP. Treatment and outcome of young patients with esophageal cancer in the Netherlands. J Surg Oncol 2014;109:561-6. [PMID: 24338660 DOI: 10.1002/jso.23533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
291 Peng YH, Xu YW, Guo H, Huang LS, Tan HZ, Hong CQ, Li SS, Xu LY, Li EM. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma. Cancer Med. 2016;5:1388-1396. [PMID: 26988995 DOI: 10.1002/cam4.702] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
292 Gür EÖ, Karaisli S, Kamer E, Kar H, Emecen AN, Ekinci N, Dilek ON, Hacıyanlı M. Predictive Factors for Lymph Node Metastasis and the Effect on Survival in Early Gastric Cancer Patients with Radical Gastric Resection. Sisli Etfal Hastan Tip Bul 2019;53:371-8. [PMID: 32377111 DOI: 10.14744/SEMB.2019.30643] [Reference Citation Analysis]
293 Ólafsdóttir HS, Klevebro F, Ndegwa N, Alexandersson von Döbeln G. Short-course compared to long-course palliative radiotherapy for oesophageal cancer: a single centre observational cohort study. Radiat Oncol 2021;16:153. [PMID: 34399793 DOI: 10.1186/s13014-021-01880-9] [Reference Citation Analysis]
294 Defize IL, Boekhoff MR, Borggreve AS, van Lier ALHMW, Takahashi N, Haj Mohammad N, Ruurda JP, van Hillegersberg R, Mook S, Meijer GJ. Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI. Acta Oncol 2020;59:753-9. [PMID: 32400242 DOI: 10.1080/0284186X.2020.1759819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
295 Xie SP, Fan GH, Kang GJ, Geng Q, Huang J, Cheng BC. Esophageal reconstruction with remnant stomach: A case report and review of literature. World J Gastroenterol 2013; 19(20): 3169-3172 [PMID: 23717001 DOI: 10.3748/wjg.v19.i20.3169] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
296 Anderegg MC, Lagarde SM, Jagadesham VP, Gisbertz SS, Immanuel A, Meijer SL, Hulshof MC, Bergman JJ, van Laarhoven HW, Griffin SM, van Berge Henegouwen MI. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction. Ann Surg 2016;264:847-53. [PMID: 27429034 DOI: 10.1097/SLA.0000000000001767] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
297 Radlinski M, Martin LW, Walters DM, Northup P, Wang AY, Rodee T, Sauer BG, Shami VM. Use of endoscopic ultrasound in pre-treatment staging of esophageal cancer did not alter management plan. J Thorac Dis 2020;12:5850-6. [PMID: 33209417 DOI: 10.21037/jtd-20-1299] [Reference Citation Analysis]
298 Vollenbrock SE, Nowee ME, Voncken FEM, Kotte ANTJ, Goense L, van Rossum PSN, van Lier ALHMW, Heijmink SW, Bartels-Rutten A, Wessels FJ, Aleman BMP, Dewit L, Kerkmeijer LGW, Jansen EPM, Intven M, Lips IM, Meijer GJ, Nijkamp J. Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT. Adv Radiat Oncol 2019;4:596-604. [PMID: 31673653 DOI: 10.1016/j.adro.2019.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
299 Baeg MK, Choi MG, Jung YD, Ko SH, Lim CH, Kim HH, Kim JS, Cho YK, Park JM, Lee IS, Kim SW. Esophageal Squamous Cell Carcinoma Patients Have an Increased Risk of Coexisting Colorectal Neoplasms. Gut Liver 2016;10:76-82. [PMID: 25963088 DOI: 10.5009/gnl14381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
300 Crabtree TD, Kosinski AS, Puri V, Burfeind W, Bharat A, Patterson GA, Hofstetter W, Meyers BF. Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database. Ann Thorac Surg 2013;96:382-90. [PMID: 23731608 DOI: 10.1016/j.athoracsur.2013.03.093] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
301 van Rossum PS, van Lier AL, van Vulpen M, Reerink O, Lagendijk JJ, Lin SH, van Hillegersberg R, Ruurda JP, Meijer GJ, Lips IM. Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiother Oncol. 2015;115:163-170. [PMID: 26002307 DOI: 10.1016/j.radonc.2015.04.027] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
302 Luna RA, Dolan JP, Diggs BS, Bronson NW, Sheppard BC, Schipper PH, Tieu BH, Feeney BT, Gatter KM, Vaccaro GM, Thomas CR, Hunter JG. Lymph Node Harvest During Esophagectomy Is Not Influenced by Use of Neoadjuvant Therapy or Clinical Disease Stage. J Gastrointest Surg 2015;19:1201-7. [DOI: 10.1007/s11605-015-2821-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
303 Sugawara K, Mori K, Okumura Y, Yagi K, Aikou S, Uemura Y, Yamashita H, Seto Y. Preoperative Low Vital Capacity Influences Survival After Esophagectomy for Patients with Esophageal Carcinoma. World J Surg. 2020;44:2305-2313. [PMID: 32123980 DOI: 10.1007/s00268-020-05450-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
304 Zhai S, Xue J, Wang Z, Hu L. High expression of special AT-rich sequence binding protein-1 predicts esophageal squamous cell carcinoma relapse and poor prognosis. Oncol Lett 2017;14:7455-60. [PMID: 29344188 DOI: 10.3892/ol.2017.7081] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
305 Sudo T, Iwaya T, Nishida N, Sawada G, Takahashi Y, Ishibashi M, Shibata K, Fujita H, Shirouzu K, Mori M. Expression of mesenchymal markers vimentin and fibronectin: the clinical significance in esophageal squamous cell carcinoma. Ann Surg Oncol. 2013;20 Suppl 3:S324-S335. [PMID: 22644514 DOI: 10.1245/s10434-012-2418-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
306 Suda K, Ishida Y, Kawamura Y, Inaba K, Kanaya S, Teramukai S, Satoh S, Uyama I. Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes. World J Surg. 2012;36:1608-1616. [PMID: 22392356 DOI: 10.1007/s00268-012-1538-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
307 Shim HJ, Kim DE, Hwang JE, Bae WK, Nam TK, Na KJ, Cho SH, Chung IJ. A phase II study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced oesophageal cancer. Cancer Chemother Pharmacol 2012;70:683-90. [PMID: 22932694 DOI: 10.1007/s00280-012-1962-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
308 Hiller JG, Hacking MB, Link EK, Wessels KL, Riedel BJ. Perioperative epidural analgesia reduces cancer recurrence after gastro-oesophageal surgery: Epidurals and gastro-oesophageal cancer. Acta Anaesthesiol Scand 2014;58:281-90. [DOI: 10.1111/aas.12255] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
309 Tustumi F, Kimura CM, Takeda FR, Sallum RA, Ribeiro-Junior U, Cecconello I. EVALUATION OF LYMPHATIC SPREAD, VISCERAL METASTASIS AND TUMORAL LOCAL INVASION IN ESOPHAGEAL CARCINOMAS. Arq Bras Cir Dig 2016;29:215-7. [PMID: 28076472 DOI: 10.1590/0102-6720201600040001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
310 Koelzer VH, Langer R, Zlobec I, Lugli A. Tumor budding in upper gastrointestinal carcinomas. Front Oncol 2014;4:216. [PMID: 25177546 DOI: 10.3389/fonc.2014.00216] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
311 Stefanowicz D, Lee JY, Lee K, Shaheen F, Koo HK, Booth S, Knight DA, Hackett TL. Elevated H3K18 acetylation in airway epithelial cells of asthmatic subjects. Respir Res 2015;16:95. [PMID: 26243279 DOI: 10.1186/s12931-015-0254-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
312 Findlay JM, Bradley KM, Wang LM, Franklin JM, Teoh EJ, Gleeson FV, Maynard ND, Gillies RS, Middleton MR. Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized Therapy. J Nucl Med 2017;58:266-75. [PMID: 27635027 DOI: 10.2967/jnumed.116.176313] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
313 Wang D, Smit JK, Zwaan E, Muijs CT, Groen H, Hollema H, Plukker JT. Neoadjuvant therapy reduces the incidence of nodal micrometastases in esophageal adenocarcinoma. The American Journal of Surgery 2013;206:732-8. [DOI: 10.1016/j.amjsurg.2013.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
314 Yoshimura S, Takahashi M, Aikou S, Okumura Y, Jinbo K, Onoyama H, Urabe M, Kawasaki K, Yagi K, Nishida M, Mori K, Yamashita H, Nomura S, Koyama K, Momose T, Abe H, Ushiku T, Fukayama M, Seto Y. One-by-One Comparison of Lymph Nodes Between 18F-FDG Uptake and Pathological Diagnosis in Esophageal Cancer. Clin Nucl Med 2020;45:741-6. [PMID: 32796247 DOI: 10.1097/RLU.0000000000003224] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
315 Gao C, Pang L, Ren C, Ma T. Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma. Pathol Oncol Res 2012;18:471-7. [PMID: 22102006 DOI: 10.1007/s12253-011-9470-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
316 Molena D, Mungo B, Stem M, Poupore AK, Chen SY, Lidor AO. Does Quality of Care Matter? A Study of Adherence to National Comprehensive Cancer Network Guidelines for Patients with Locally Advanced Esophageal Cancer. J Gastrointest Surg 2015;19:1739-47. [PMID: 26245634 DOI: 10.1007/s11605-015-2899-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
317 Boers J, Joldersma A, van Dalsen AD, Wiegman EM, Schenk BE, de Graaf JC, Pierik EGJM, Timmer PR, de Groot JWB. Intensified Neoadjuvant Chemoradiotherapy for Patients with Potentially Resectable Esophageal Cancer: A Retrospective Cohort Study. Ann Surg Oncol 2020;27:1520-8. [PMID: 31828691 DOI: 10.1245/s10434-019-08114-z] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
318 Ji W, Zheng W, Li B, Cao C, Mao W. Influence of body mass index on the long-term outcomes of patients with esophageal squamous cell carcinoma who underwent esophagectomy as a primary treatment: A 10-year medical experience. Medicine (Baltimore) 2016;95:e4204. [PMID: 27442643 DOI: 10.1097/MD.0000000000004204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.2] [Reference Citation Analysis]
319 Mamdani H, Birdas T, Jalal SI. Role of surgery following neoadjuvant chemoradiation in patients with lymph node positive locally advanced esophageal adenocarcinoma: a national cancer database analysis. J Gastrointest Oncol 2021;12:1944-50. [PMID: 34790362 DOI: 10.21037/jgo-21-314] [Reference Citation Analysis]
320 Wang L, Lin Y, Long H, Liu H, Rao H, He Y, Rong T, Liang Y. Esophageal carcinosarcoma: a unique entity with better prognosis. Ann Surg Oncol. 2013;20:997-1004. [PMID: 23010734 DOI: 10.1245/s10434-012-2658-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
321 Lorimer PD, Motz BM, Boselli DM, Reames MK, Hill JS, Salo JC. Quality Improvement in Minimally Invasive Esophagectomy: Outcome Improvement Through Data Review. Ann Surg Oncol 2019;26:177-87. [PMID: 30382434 DOI: 10.1245/s10434-018-6938-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
322 Xie SP, Kang GJ, Fan GH, Geng Q, Huang J. Ivor-Lewis esophagectomy for esophageal cancer after distal gastrectomy. J Thorac Dis. 2014;6:E22-E26. [PMID: 24605241 DOI: 10.3978/j.issn.2072-1439.2014.02.03] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
323 Xie Y, Wang Q, Cao B, Lv J, Wang Y, Wu L, Dong M, Li T. Textural features based enhanced contrast CT images predicts prognosis to concurrent chemoradiotherapy in stage III esophageal squamous cell cancer. Cancer Biomark 2020;27:325-33. [PMID: 31903981 DOI: 10.3233/CBM-190586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
324 Yan SM, Liu L, Gu WY, Huang LY, Yang Y, Huang YH, Luo RZ. CEP55 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma and Is Correlated with Poor Prognosis. J Oncol 2021;2021:8890715. [PMID: 34104194 DOI: 10.1155/2021/8890715] [Reference Citation Analysis]
325 Chen WX, Hong XB, Hong CQ, Liu M, Li L, Huang LS, Xu LY, Xu YW, Peng YH, Li EM. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma. Clin Res Hepatol Gastroenterol. 2017;41:327-332. [PMID: 27956255 DOI: 10.1016/j.clinre.2016.10.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
326 Sathe TS, Resio BJ, Hoag JR, Monsalve AF, Pathak R, Blasberg JD, Mase V Jr, Dhanasopon A, Boffa DJ. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database. Ann Thorac Surg 2020;109:1656-62. [PMID: 32109449 DOI: 10.1016/j.athoracsur.2020.01.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
327 Sankalecha TH, Gupta SJ, Gaikwad NR, Shirole NU, Kothari HG. Yield of p53 expression in esophageal squamous cell cancer and its relationship with survival. Saudi J Gastroenterol 2017;23:281-6. [PMID: 28937022 DOI: 10.4103/sjg.SJG_56_17] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
328 Zhong Q, Sun Q, Xu GF, Fan XQ, Xu YY, Liu F, Song SY, Peng CY, Wang L. Differential analysis of lymph node metastasis in histological mixed-type early gastric carcinoma in the mucosa and submucosa. World J Gastroenterol 2018; 24(1): 87-95 [PMID: 29358885 DOI: 10.3748/wjg.v24.i1.87] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
329 Huang Q, Zhong J, Yang T, Li J, Luo K, Zheng Y, Yang H, Fu J. Impacts of anastomotic complications on the health-related quality of life after esophagectomy: HRQL After Esophagectomy. J Surg Oncol 2015;111:365-70. [DOI: 10.1002/jso.23837] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
330 Berry MF. Esophageal Cancer: Improvements in Treatment, Staging, and Now Prognostic Indicators? Semin Thorac Cardiovasc Surg 2016;28:559-60. [PMID: 28043476 DOI: 10.1053/j.semtcvs.2016.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
331 Day RW, Badgwell BD, Fournier KF, Mansfield PF, Aloia TA. Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy. J Gastrointest Surg 2016;20:146-53; discussion 153. [PMID: 26416411 DOI: 10.1007/s11605-015-2949-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
332 Eto K, Yoshida N, Iwatsuki M, Kurashige J, Ida S, Ishimoto T, Baba Y, Sakamoto Y, Miyamoto Y, Watanabe M, Baba H. Surgical Apgar Score Predicted Postoperative Morbidity After Esophagectomy for Esophageal Cancer. World J Surg 2016;40:1145-51. [DOI: 10.1007/s00268-016-3425-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
333 Li Y, Wen Z, Yang H, Luo R, Zhang Y, Zhang M, Wang X, Jia W. High Expression of Y-Box-Binding Protein-1 is Associated with Poor Survival in Resectable Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2011;18:3370-6. [DOI: 10.1245/s10434-011-1725-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
334 Tamtai A, Jiarpinitnun C, Hiranyatheb P, Unwanatham N, Sirachainun E, Supsamutchai C, Pattaranutaporn P, Ngamphaiboon N. Tolerability and efficacy of concurrent chemoradiotherapy comparing carboplatin/paclitaxel versus platinum/5-FU regimen for locally advanced esophageal and esophagogastric junction cancers. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-1017-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
335 Yoon HH, Sukov WR, Shi Q, Sattler CA, Wiktor AE, Diasio RB, Wu TT, Jenkins RB, Sinicrope FA. HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma. Cancer 2014;120:415-24. [PMID: 24151090 DOI: 10.1002/cncr.28435] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
336 Javidfar J, Bacchetta M, Yang JA, Miller J, D’Ovidio F, Ginsburg ME, Gorenstein LA, Bessler M, Sonett JR. The use of a tailored surgical technique for minimally invasive esophagectomy. J Thorac Cardiovasc Surg. 2012;143:1125-1129. [PMID: 22500593 DOI: 10.1016/j.jtcvs.2012.01.071] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
337 Guo JH, Chen MQ, Chen C, Lu HJ, Xu BH. Efficacy and toxicity of nimotuzumab combined with radiotherapy in elderly patients with esophageal squamous cell carcinoma. Mol Clin Oncol 2015;3:1135-8. [PMID: 26623065 DOI: 10.3892/mco.2015.606] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
338 Cheng JC, Graber MS, Hsu F, Tsai C, Castaneda L, Lee J, Chang DT, Koong AC. High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy. Ann Surg Oncol 2014;21:2361-8. [DOI: 10.1245/s10434-014-3611-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
339 Ruan R, Chen S, Tao Y, Yu J, Zhou D, Cui Z, Shen Q, Wang S. A Nomogram for Predicting Lymphovascular Invasion in Superficial Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:663802. [PMID: 34041028 DOI: 10.3389/fonc.2021.663802] [Reference Citation Analysis]
340 Zhu Y, Li M, Kong L, Yu J. Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation. Onco Targets Ther 2016;9:4187-96. [PMID: 27471393 DOI: 10.2147/OTT.S104221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
341 Qin J, Wu SG, Sun JY, Lin HX, He ZY, Li Q. Effect of blood type on survival of Chinese patients with esophageal squamous cell carcinoma. Onco Targets Ther 2015;8:947-53. [PMID: 25960667 DOI: 10.2147/OTT.S81936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
342 Chen XL, Chen TW, Fang ZJ, Zhang XM, Li ZL, Li H, Tang HJ, Zhou L, Wang D, Zhang Z. Patterns of lymph node recurrence after radical surgery impacting on survival of patients with pT1-3N0M0 thoracic esophageal squamous cell carcinoma. J Korean Med Sci 2014;29:217-23. [PMID: 24550648 DOI: 10.3346/jkms.2014.29.2.217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
343 Francis SR, Anker CJ, Wang B, Williams GV, Cox K, Adler DG, Shrieve DC, Salter BJ. Self-expanding stent effects on radiation dosimetry in esophageal cancer. J Appl Clin Med Phys 2013;14:4218. [PMID: 23835387 DOI: 10.1120/jacmp.v14i4.4218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
344 Shin KE, Lee KS, Choi JY, Kim HK, Shim YM. Esophageal malignancy and staging. Semin Roentgenol 2013;48:344-53. [PMID: 24034266 DOI: 10.1053/j.ro.2013.03.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
345 Jezerskyte E, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. Gastro-esophageal junction cancers: what is the best minimally invasive approach? J Thorac Dis 2017;9:S751-60. [PMID: 28815071 DOI: 10.21037/jtd.2017.06.56] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
346 Erhunmwunsee L, Englum BR, Onaitis MW, D'Amico TA, Berry MF. Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions. Ann Surg Oncol. 2015;22:1020-1025. [PMID: 25234017 DOI: 10.1245/s10434-014-4079-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
347 Wu J, Chen QX, Zhou XM, Mao WM, Krasna MJ. Does recurrent laryngeal nerve lymph node metastasis really affect the prognosis in node-positive patients with squamous cell carcinoma of the middle thoracic esophagus? BMC Surg 2014;14:43. [PMID: 25016483 DOI: 10.1186/1471-2482-14-43] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
348 Xing XZ, Gao Y, Wang HJ, Qu SN, Huang CL, Zhang H, Wang H, Yang QH. Assessment of a predictive score for pulmonary complications in cancer patients after esophagectomy. World J Emerg Med 2016;7:44-9. [PMID: 27006738 DOI: 10.5847/wjem.j.1920-8642.2016.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
349 Cao X, Zhang L, Feng GR, Yang J, Wang RY, Li J, Zheng XM, Han YJ. Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma. J Transl Med. 2012;10:197. [PMID: 22999061 DOI: 10.1186/1479-5876-10-197] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
350 Yue-Yun C, Ye H, Yang F, Qing L, Pan-Pan L, Zhen-Yu D. Sequential Administration of EGFR-TKI and Pemetrexed Achieved a Long Duration of Response in Advanced NSCLC Patients with EGFR-mutant Tumours. Asian Pac J Cancer Prev 2019;20:2415-20. [PMID: 31450915 DOI: 10.31557/APJCP.2019.20.8.2415] [Reference Citation Analysis]
351 Mu JW, Gao SG, Xue Q, Mao YS, Wang DL, Zhao J, Gao YS, Huang JF, He J. Comparison of short-term outcomes and three yearsurvival between total minimally invasive McKeown and dual-incision esophagectomy. Thorac Cancer 2017;8:80-7. [PMID: 28052566 DOI: 10.1111/1759-7714.12404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
352 Yap W, Chang Y, Hsieh C, Chao Y, Chen C, Shih M, Hung T. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. Eur J Nucl Med Mol Imaging 2018;45:689-98. [DOI: 10.1007/s00259-017-3901-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
353 Lin J, Goldstein L, Nesbit A, Chen MY. Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer. World Neurosurg 2016;85:42-8. [PMID: 26260940 DOI: 10.1016/j.wneu.2015.07.068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
354 Burtness B, Ilson D, Iqbal S. New Directions in Perioperative Management of Locally Advanced Esophagogastric Cancer. American Society of Clinical Oncology Educational Book 2014. [DOI: 10.14694/edbook_am.2014.34.e172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
355 Hattori T, Sentani K, Hattori Y, Oue N, Yasui W. Pure invasive micropapillary carcinoma of the esophagogastric junction with lymph nodes and liver metastasis. Pathol Int 2016;66:583-6. [PMID: 27553658 DOI: 10.1111/pin.12450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
356 Chen SB, Weng HR, Wang G, Zou XF, Liu DT, Chen YP, Zhang H. Lymph node ratio-based staging system for esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(24): 7514-7521 [PMID: 26139998 DOI: 10.3748/wjg.v21.i24.7514] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
357 Tan T, Zhang K, Sun WC. Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population. Breast Cancer 2017;24:369-74. [DOI: 10.1007/s12282-016-0712-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
358 Zhang HD, Chen CG, Gao YY, Ma Z, Tang P, Duan XF, Ren P, Yue J, Yu ZT. Primary esophageal adenosquamous carcinoma: a retrospective analysis of 24 cases. Dis Esophagus 2014;27:783-9. [PMID: 24127755 DOI: 10.1111/dote.12153] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
359 Sun H, Gong L, Zhao G, Zhan H, Meng B, Yu Z, Pan Z. Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus. J Surg Oncol. 2018;117:588-596. [PMID: 29266237 DOI: 10.1002/jso.24905] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
360 Walterbos NR, Fiocco M, Neelis KJ, van der Linden YM, Langers AMJ, Slingerland M, de Steur WO, Peters FP, Lips IM. Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer. Clin Transl Radiat Oncol 2019;17:24-31. [PMID: 31193091 DOI: 10.1016/j.ctro.2019.04.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
361 Mu JW, Gao SG, Xue Q, Mao YS, Wang DL, Zhao J, Gao YS, Huang JF, He J. Updated experiences with minimally invasive McKeown esophagectomy for esophageal cancer. World J Gastroenterol 2015; 21(45): 12873-12881 [PMID: 26668512 DOI: 10.3748/wjg.v21.i45.12873] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
362 Findlay JM, Gillies RS, Franklin JM, Teoh EJ, Jones GE, di Carlo S, Gleeson FV, Maynard ND, Bradley KM, Middleton MR. Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery. Eur Radiol 2016;26:3519-33. [PMID: 26883329 DOI: 10.1007/s00330-016-4227-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
363 Cools-Lartigue J, Spicer J, Ferri LE. Current status of management of malignant disease: current management of esophageal cancer. J Gastrointest Surg 2015;19:964-72. [PMID: 25650163 DOI: 10.1007/s11605-014-2701-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
364 St-Amour P, Winiker M, Sempoux C, Fasquelle F, Demartines N, Schäfer M, Mantziari S. The "Real R0": A Resection Margin Smaller Than 0.1 cm is Associated with a Poor Prognosis After Oncologic Esophagectomy. Ann Surg Oncol 2021. [PMID: 34041624 DOI: 10.1245/s10434-021-10121-y] [Reference Citation Analysis]
365 Vermeulen BD, Bruggeman L, Bac DJ, Schrauwen RWM, Epping LSM, Scheffer RCH, Tan ACITL, Groenen MJM, Verhoeven RHA, Siersema PD. Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study. Acta Oncol. 2020;59:410-416. [PMID: 32067535 DOI: 10.1080/0284186x.2020.1725240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
366 Junttila A, Helminen O, Mrena J, Sihvo E. Exercise capacity in the stair-climbing test predicts outcomes of operable esophageal cancer in minimally invasive era. Eur J Surg Oncol 2021:S0748-7983(21)00774-5. [PMID: 34740478 DOI: 10.1016/j.ejso.2021.10.024] [Reference Citation Analysis]
367 Guo X, Zhang H, Xu L, Zhou S, Zhou J, Liu Y, Ji S. Value of Nomogram Incorporated Preoperative Tumor Volume and the Number of Postoperative Pathologically Lymph Node Metastasis Regions on Predicting the Prognosis of Thoracic Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:4619-31. [PMID: 34140808 DOI: 10.2147/CMAR.S307764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
368 Shan TT, Zhao X, Zhang Z, Wang JP, Zhang Y, Yang Y, Zhao S. Clinical Significance of Down-Regulated CD70 and CD27 Expression in Poor Prognosis of Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:6909-20. [PMID: 33204151 DOI: 10.2147/CMAR.S241377] [Reference Citation Analysis]
369 Hadlich E, Carbonari APC, Assef MS, Araki OM, Nakao FS, Saieg MTA, Rossini LGB. Esophageal adenocarcinoma metastasis in the left adrenal gland diagnosed by endoscopic ultrasound-guided fine needle aspiration. Endosc Ultrasound 2017;6:142-4. [PMID: 28440242 DOI: 10.4103/2303-9027.204809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
370 Zheng Y, Li Y, Xing W, Qin J, Liu X, Zhang R, Sun H, Chen X. Serum Fibrinogen Is An Independent Prognostic Factor In Operable Esophageal Squamous Carcinoma: A Real-World Study. Cancer Manag Res 2019;11:8877-83. [PMID: 31632147 DOI: 10.2147/CMAR.S212192] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
371 Offman J, Pesola F, Sasieni P. Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037. Br J Cancer 2018;118:1391-8. [PMID: 29563637 DOI: 10.1038/s41416-018-0047-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
372 Jin P, Hulshof MC, van Wieringen N, Bel A, Alderliesten T. Interfractional variability of respiration-induced esophageal tumor motion quantified using fiducial markers and four-dimensional cone-beam computed tomography. Radiotherapy and Oncology 2017;124:147-54. [DOI: 10.1016/j.radonc.2017.05.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
373 Wen XD, Wen DG, Yang Y, Shan BE, Wang SJ. Earlier onset and multiple primaries in familial as opposed to sporadic esophageal cancer. World J Med Genet 2014; 4(2): 39-45 [DOI: 10.5496/wjmg.v4.i2.39] [Reference Citation Analysis]
374 Lin CS, Huang YY, Pan SC, Cheng CT, Liu CC, Shih CH, Ho HL, Yeh YC, Chou TY, Lee MY, Wei YH. Involvement of increased p53 expression in the decrease of mitochondrial DNA copy number and increase of SUVmax of FDG-PET scan in esophageal squamous cell carcinoma. Mitochondrion 2019;47:54-63. [PMID: 31071450 DOI: 10.1016/j.mito.2019.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
375 Hu K, Kang N, Liu Y, Guo D, Jing W, Lu J, Tan T, Lv C, Deng Y, Long J, Wang R, Yu J. Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancer. Cancer Sci 2019;110:717-25. [PMID: 30467921 DOI: 10.1111/cas.13891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
376 Zhang H, Wang W, Diao D, Cheng Y, Song Y, Zhu K, Dang C. Ratio of metastatic to examined lymph nodes, a helpful staging system and independent prognostic factor of esophagogastric junction cancer. PLoS One. 2013;8:e73238. [PMID: 23977381 DOI: 10.1371/journal.pone.0073238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
377 Li B, Hu H, Zhang Y, Zhang J, Miao L, Ma L, Luo X, Zhang Y, Ye T, Li H, Li Y, Shen L, Zhao K, Fan M, Zhu Z, Wang J, Xu J, Deng Y, Lu Q, Li H, Zhang Y, Pan Y, Liu S, Hu H, Shao L, Sun Y, Xiang J, Chen H. Three-field versus two-field lymphadenectomy in transthoracic oesophagectomy for oesophageal squamous cell carcinoma: short-term outcomes of a randomized clinical trial. Br J Surg 2020;107:647-54. [PMID: 32108326 DOI: 10.1002/bjs.11497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
378 Tabchi S, Blais N, Campeau MP, Tehfe M. Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer. Cancer Chemother Pharmacol 2017;79:381-7. [PMID: 28083648 DOI: 10.1007/s00280-016-3226-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
379 Chen MQ, Chen C, Lu HJ, Xu BH. The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma. J Thorac Dis. 2015;7:1749-1755. [PMID: 26623097 DOI: 10.3978/j.issn.2072-1439.2015.10.23] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
380 Findlay JM, Bradley KM, Maile EJ, Braden B, Maw J, Phillips-Hughes J, Gillies RS, Maynard ND, Middleton MR. Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy. Br J Surg 2015;102:1488-99. [PMID: 26458070 DOI: 10.1002/bjs.9905] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
381 Hsieh CC, Hsu HS, Chang SC, Chen YJ. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma. Int J Mol Sci. 2016;17:2131. [PMID: 27999323 DOI: 10.3390/ijms17122131] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
382 Liu Q, Qiu Y, Deng X, Min J, Dai J. Comparison of outcomes following end-to-end hand-sewn and mechanical oesophagogastric anastomosis after oesophagectomy for carcinoma: a prospective randomized controlled trial. European Journal of Cardio-Thoracic Surgery 2015;47:e118-23. [DOI: 10.1093/ejcts/ezu457] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
383 Milstein DM, Ince C, Gisbertz SS, Boateng KB, Geerts BF, Hollmann MW, van Berge Henegouwen MI, Veelo DP. Laser speckle contrast imaging identifies ischemic areas on gastric tube reconstructions following esophagectomy. Medicine (Baltimore). 2016;95:e3875. [PMID: 27336874 DOI: 10.1097/md.0000000000003875] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 6.4] [Reference Citation Analysis]
384 Chen WS, Zhu LH, Li WJ, Tu PJ, Huang JY, You PL, Pan XJ. Novel technique for lymphadenectomy along left recurrent laryngeal nerve during thoracoscopic esophagectomy. World J Gastroenterol 2020; 26(12): 1340-1351 [PMID: 32256021 DOI: 10.3748/wjg.v26.i12.1340] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
385 Park SY, Jung I, Heo SJ, Byun GE, Lee EY, Kim DJ. Comparison of QoL Between Substernal and Posterior Mediastinal Routes in Esophagogastrostomy. J Gastrointest Surg 2021;25:635-40. [PMID: 32779083 DOI: 10.1007/s11605-020-04766-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
386 Wu YF, Chu SC, Chang BS, Cheng YT, Wang TF. Hematologic Markers as Prognostic Factors in Nonmetastatic Esophageal Cancer Patients under Concurrent Chemoradiotherapy. Biomed Res Int 2019;2019:1263050. [PMID: 30834254 DOI: 10.1155/2019/1263050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
387 Lin CS, Cheng CT, Liu CY, Lee MY, Hsiao MC, Shih CH, Liu CC. Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2015;100:278-86. [PMID: 26002444 DOI: 10.1016/j.athoracsur.2015.02.053] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
388 Ling Y, Huang G, Fan L, Wei L, Zhu J, Liu Y, Zhu C, Zhang C. CpG island methylator phenotype of cell-cycle regulators associated with TNM stage and poor prognosis in patients with oesophageal squamous cell carcinoma. J Clin Pathol 2011;64:246-51. [DOI: 10.1136/jcp.2010.082875] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
389 Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ogata Y, Eto K, Hiyoshi Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer. Cancer Sci 2019;110:1863-71. [PMID: 31012515 DOI: 10.1111/cas.14028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
390 Sun YH, Lin SW, Chen CH, Liang WY, Hsieh CC. Adenosquamous Carcinoma of the Esophagus and Esophagogastric Junction: Clinical Manifestations and Treatment Outcomes. J Gastrointest Surg 2015;19:1216-22. [PMID: 25967141 DOI: 10.1007/s11605-015-2852-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
391 Kleinberg L. Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcome. Semin Radiat Oncol. 2013;23:38-50. [PMID: 23207046 DOI: 10.1016/j.semradonc.2012.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
392 Seol KH, Lee JE. PET/CT planning during chemoradiotherapy for esophageal cancer. Radiat Oncol J 2014;32:31-42. [PMID: 24724049 DOI: 10.3857/roj.2014.32.1.31] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
393 Han H, Pan M, Tao Y, Liu R, Huang Z, Piccolo K, Zhong C, Liu R. Early Enteral Nutrition is Associated with Faster Post-Esophagectomy Recovery in Chinese Esophageal Cancer Patients: A Retrospective Cohort Study. Nutr Cancer. 2018;70:221-228. [PMID: 29313724 DOI: 10.1080/01635581.2018.1412477] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
394 de Geus SWL, Hirji S, Hachey KJ, Sachs TE, Suzuki K, Ng SC, Swanson S, Litle VR, D'Amico T, Tseng JF. Lymphadenectomy and Survival After Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma: Is More Better? J Gastrointest Surg 2020;24:2447-55. [PMID: 32875442 DOI: 10.1007/s11605-020-04750-z] [Reference Citation Analysis]
395 Zhou K, Zhang SS, Yan Y, Zhao S. Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma. Med Oncol 2014;31:17. [PMID: 24878697 DOI: 10.1007/s12032-014-0017-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
396 Hoshino A, Nakajima Y, Kawada K, Tokairin Y, Okada T, Matsui T, Yamaguchi K, Kawano T, Kinugasa Y. The Impact of Hybrid Minimally Invasive Esophagectomy with Neck-Abdominal First Approach on the Short- and Long-Term Outcomes for Esophageal Squamous Cell Carcinoma. World J Surg 2020;44:3829-36. [PMID: 32591842 DOI: 10.1007/s00268-020-05655-3] [Reference Citation Analysis]
397 Allum WH, Bonavina L, Cassivi SD, Cuesta MA, Dong ZM, Felix VN, Figueredo E, Gatenby PA, Haverkamp L, Ibraev MA, Krasna MJ, Lambert R, Langer R, Lewis MP, Nason KS, Parry K, Preston SR, Ruurda JP, Schaheen LW, Tatum RP, Turkin IN, van der Horst S, van der Peet DL, van der Sluis PC, van Hillegersberg R, Wormald JC, Wu PC, Zonderhuis BM. Surgical treatments for esophageal cancers. Ann N Y Acad Sci. 2014;1325:242-268. [PMID: 25266029 DOI: 10.1111/nyas.12533] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
398 Xiong J, Wang Y, Kang W, Ma F, Liu H, Ma S, Li Y, Jin P, Hu H, Tian Y. Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction. Front Oncol 2020;10:595793. [PMID: 33392090 DOI: 10.3389/fonc.2020.595793] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
399 Frankel A, Armour N, Nancarrow D, Krause L, Hayward N, Lampe G, Smithers BM, Barbour A. Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis. Genes Chromosomes Cancer 2014;53:324-38. [PMID: 24446147 DOI: 10.1002/gcc.22143] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
400 Vieira FM, Chedid MF, Gurski RR, Schirmer CC, Cavazzola LT, Schramm RV, Rosa ARP, Kruel CDP. TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS? Arq Bras Cir Dig 2021;33:e1567. [PMID: 33759957 DOI: 10.1590/0102-672020200004e1567] [Reference Citation Analysis]
401 Goense L, Merrell KW, Arnett AL, Hallemeier CL, Meijer GJ, Ruurda JP, Hofstetter WL, van Hillegersberg R, Lin SH. Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer. The Annals of Thoracic Surgery 2018;106:1541-7. [DOI: 10.1016/j.athoracsur.2018.05.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
402 Vollenbrock SE, Voncken FEM, Lambregts DMJ, Maas M, Donswijk ML, Vegt E, Ter Beek LC, van Dieren JM, van Sandick JW, Aleman BMP, Beets-Tan RGH, Bartels-Rutten A. Clinical response assessment on DW-MRI compared with FDG-PET/CT after neoadjuvant chemoradiotherapy in patients with oesophageal cancer. Eur J Nucl Med Mol Imaging 2021;48:176-85. [PMID: 32572560 DOI: 10.1007/s00259-020-04917-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
403 Liu QX, Deng XF, Wang JS, Hou B, Li JM, Min JX, Dai JG. Use of oesophageal flap valvuloplasty and wrapping suturing technique in preventing postoperative complications after oesophagectomy for oesophageal cancer. Eur J Surg Oncol 2014;40:1355-60. [PMID: 24835379 DOI: 10.1016/j.ejso.2014.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
404 Cellini F, Morganti AG, Di Matteo FM, Mattiucci GC, Valentini V. Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach. Radiat Oncol 2014;9:45. [PMID: 24499595 DOI: 10.1186/1748-717X-9-45] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
405 Wang H, Lin Z, Lin Y, Huang R, Qiu M, Peng X, He F, Huang L, Xiang Z, Lu W, Yan S, Liu S, Yang H, Zhang Z, Hu Z. Optimal Size Criterion for Malignant Lymph Nodes and a Novel Lymph Node Clinical Staging System for Unresectable Esophageal Squamous Cell Carcinoma: Evaluation by Multislice Spiral Computed Tomography. J Cancer 2021;12:6454-64. [PMID: 34659536 DOI: 10.7150/jca.61994] [Reference Citation Analysis]
406 Qi W, Zixiang W, Tianwei Z, Shuai F, Sai Z, Gang S, Ming W. Long-term outcomes of 530 esophageal squamous cell carcinoma patients with minimally invasive Ivor Lewis esophagectomy. J Surg Oncol. 2018;117:957-969. [PMID: 29878389 DOI: 10.1002/jso.24997] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
407 Fisher OM, Lord SJ, Falkenback D, Clemons NJ, Eslick GD, Lord RV. The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis. Gut 2017;66:399-410. [PMID: 26733670 DOI: 10.1136/gutjnl-2015-310888] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
408 Isidori F, Bozzarelli I, Mastracci L, Malvi D, Lugaresi M, Molinari C, Söderström H, Räsänen J, D'Errico A, Fiocca R, Seri M, Krishnadath KK, Bonora E, Mattioli S. Targeted Sequencing of Sorted Esophageal Adenocarcinoma Cells Unveils Known and Novel Mutations in the Separated Subpopulations. Clin Transl Gastroenterol 2020;11:e00202. [PMID: 33094962 DOI: 10.14309/ctg.0000000000000202] [Reference Citation Analysis]
409 Chang YJ, Huang JY, Lin CH, Wang BY. Survival and Treatment of Lung Cancer in Taiwan between 2010 and 2016. J Clin Med 2021;10:4675. [PMID: 34682798 DOI: 10.3390/jcm10204675] [Reference Citation Analysis]
410 Chen JW, Xie JD, Ling YH, Li P, Yan SM, Xi SY, Luo RZ, Yun JP, Xie D, Cai MY. The prognostic effect of perineural invasion in esophageal squamous cell carcinoma. BMC Cancer. 2014;14:313. [PMID: 24886020 DOI: 10.1186/1471-2407-14-313] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
411 Hou X, Wei JC, Fu JH, Wang X, Zhang LJ, Lin P, Yang HX. Proposed modification of the seventh American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma in Chinese patients. Ann Surg Oncol 2014;21:337-42. [PMID: 24046121 DOI: 10.1245/s10434-013-3265-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
412 Miao H, Li R, Chen D, Hu J, Chen Y, Wen Z. Survival outcomes and prognostic factors of primary small cell carcinoma of the esophagus. J Thorac Dis 2021;13:2790-802. [PMID: 34164171 DOI: 10.21037/jtd-20-3334] [Reference Citation Analysis]
413 Song JH, Ko J, Min YW, Kim K, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ. Comparison between Percutaneous Gastrostomy and Self-Expandable Metal Stent Insertion for the Treatment of Malignant Esophageal Obstruction, after Propensity Score Matching. Nutrients 2020;12:E2756. [PMID: 32927691 DOI: 10.3390/nu12092756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Yamamura K, Izumi D, Kandimalla R, Sonohara F, Baba Y, Yoshida N, Kodera Y, Baba H, Goel A. Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Clin Cancer Res 2019;25:6170-9. [PMID: 31358543 DOI: 10.1158/1078-0432.CCR-19-0318] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
415 Encaoua J, Abgral R, Leleu C, El Kabbaj O, Caradec P, Bourhis D, Pradier O, Schick U. Intérêt de la tomographie par émission de positons au ( 18 F)-fluorodésoxyglucose pour la planification de la radiothérapie des cancers de l’œsophage localement évolués ou inopérables. Cancer/Radiothérapie 2017;21:267-75. [DOI: 10.1016/j.canrad.2016.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
416 Cho CJ, Kang HJ, Park SJ, Kim GH, Park SH, Eo SH, Kim MJ, Kim YH, Park SR, Kim JH, Ahn JY, Kim DH, Choi KD, Song HJ, Jung HY, Park YS, Lee GH. Novel endoscopic categorization for prediction of chemoradiotherapy response in locally advanced esophageal cancer. J Gastroenterol Hepatol 2018;33:1213-9. [PMID: 29193280 DOI: 10.1111/jgh.14055] [Reference Citation Analysis]
417 Beukema JC, Kawaguchi Y, Sijtsema NM, Zhai T, Langendijk JA, van Dijk LV, van Luijk P, Teshima T, Muijs CT. Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients? Radiotherapy and Oncology 2020;149:222-7. [DOI: 10.1016/j.radonc.2020.05.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
418 Wang L, Milman S, Ng T. Performance of the transoral circular stapler for oesophagogastrectomy after induction therapy. Interact Cardiovasc Thorac Surg 2019;29:890-6. [PMID: 31436809 DOI: 10.1093/icvts/ivz203] [Reference Citation Analysis]
419 Howard JM, Cathcart MC, Healy L, Beddy P, Muldoon C, Pidgeon GP, Reynolds JV. Leptin and adiponectin receptor expression in oesophageal cancer. Br J Surg 2014;101:643-52. [PMID: 24664553 DOI: 10.1002/bjs.9469] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
420 Rantanen T, Kauttu T, Åkerla J, Honkanen T, Krogerus L, Salo J, Paavonen T, Oksala N. CIP2A expression and prognostic role in patients with esophageal adenocarcinoma. Med Oncol 2013;30:684. [PMID: 23925667 DOI: 10.1007/s12032-013-0684-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
421 Lu D, Liu X, Feng S, Dong X, Shi X, Ren P, Diao D, Wu H, Xiong G, Wang H, Li M, Rao S, Molena D, Wu AJ, Cai K. The Current Situation of Esophageal Cancer Staging and Perioperative Strategies Determination in Central and Southern China: A Cross Sectional Survey. Front Oncol 2019;9:1098. [PMID: 31696056 DOI: 10.3389/fonc.2019.01098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
422 Hou X, Gu YK, Liu XW, Fu JH, Wang X, Zhang LJ, Luo RZ, Lin P, Yang HX. The impact of tumor cell differentiation on survival of patients with resectable esophageal squamous cell carcinomas. Ann Surg Oncol 2015;22:1008-14. [PMID: 25201504 DOI: 10.1245/s10434-014-4067-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
423 Martin JT, Mahan A, Zwischenberger JB, McGrath PC, Tzeng CW. Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients. J Am Coll Surg 2015;220:510-20. [PMID: 25667138 DOI: 10.1016/j.jamcollsurg.2014.12.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
424 Goense L, van der Sluis PC, van Rossum PSN, van der Horst S, Meijer GJ, Haj Mohammad N, van Vulpen M, Mook S, Ruurda JP, van Hillegersberg R. Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival. J Surg Oncol 2017;115:812-20. [PMID: 28267212 DOI: 10.1002/jso.24596] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
425 Nakauchi M, Uyama I, Suda K, Shibasaki S, Kikuchi K, Kadoya S, Ishida Y, Inaba K. Robot-assisted mediastinoscopic esophagectomy for esophageal cancer: the first clinical series. Esophagus 2019;16:85-92. [PMID: 30074105 DOI: 10.1007/s10388-018-0634-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
426 Dong X, Xing L, Wu P, Fu Z, Wan H, Li D, Yin Y, Sun X, Yu J. Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage. Nuclear Medicine Communications 2013;34:40-6. [DOI: 10.1097/mnm.0b013e32835ae50c] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
427 Sudo N, Ichikawa H, Muneoka Y, Hanyu T, Kano Y, Ishikawa T, Hirose Y, Miura K, Shimada Y, Nagahashi M, Sakata J, Kobayashi T, Bamba T, Nakagawa S, Kosugi SI, Wakai T. Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021;28:650-60. [PMID: 33025354 DOI: 10.1245/s10434-020-09181-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
428 Kim JY, Nelson RA, Kim J, Raz D. How well does pathologic stage predict survival for esophageal adenocarcinoma after neoadjuvant therapy? J Thorac Dis 2015;7:734-9. [PMID: 25973240 DOI: 10.3978/j.issn.2072-1439.2015.04.30] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
429 Thakur B, Li H, Devkota M. Results of management of esophageal and GE junction malignancies in Nepalese context. J Thorac Dis 2013;5:123-8. [PMID: 23585936 DOI: 10.3978/j.issn.2072-1439.2013.03.07] [Reference Citation Analysis]
430 Zhan C, Shi Y, Jiang W, Sun F, Li M, Lu T, Yin J, Ma K, Yang X, Wang Q. How many lymph nodes should be dissected in esophagectomy with or without neoadjuvant therapy to get accurate staging? Dis Esophagus 2020;33:doz009. [PMID: 30997490 DOI: 10.1093/dote/doz009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
431 Nguyen TN, Hummel R, Bright T, Thompson SK, Tornqvist B, Watson DI. Pattern of care for cancer of the oesophagus in a western population. ANZ J Surg 2019;89:E15-9. [PMID: 29885201 DOI: 10.1111/ans.14685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
432 de Man FM, van Eerden RAG, Oomen-de Hoop E, Veraart JN, van Doorn N, van Doorn L, van der Gaast A, Mathijssen RHJ. Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients. Cancers (Basel) 2019;11:E826. [PMID: 31200588 DOI: 10.3390/cancers11060826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
433 Hsieh CC, Hsu HS, Li AF, Chen YJ. Clinical relevance of PD-L1 and PD-L2 overexpression in patients with esophageal squamous cell carcinoma. J Thorac Dis 2018;10:4433-44. [PMID: 30174892 DOI: 10.21037/jtd.2018.06.167] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
434 Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours. World J Gastroenterol 2018; 24(13): 1429-1439 [PMID: 29632424 DOI: 10.3748/wjg.v24.i13.1429] [Reference Citation Analysis]
435 Depypere L, Moons J, Lerut T, De Hertogh G, Sagaert X, Coosemans W, Van Veer H, Renders A, Nafteux P. Neoadjuvant chemoradiation treatment followed by surgery for esophageal cancer: there is much more than the mandard tumor regression score. Acta Chir Belg 2016;116:149-55. [PMID: 27472306 DOI: 10.1080/00015458.2016.1212500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
436 Oshikiri T, Nakamura T, Miura Y, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Sumi Y, Suzuki S, Kakeji Y. A new method (the "Pincers maneuver") for lymphadenectomy along the right recurrent laryngeal nerve during thoracoscopic esophagectomy in the prone position for esophageal cancer. Surg Endosc 2017;31:1496-504. [PMID: 27492431 DOI: 10.1007/s00464-016-5124-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
437 Liu DS, Hoefnagel SJ, Fisher OM, Krishnadath KK, Montgomery KG, Busuttil RA, Colebatch AJ, Read M, Duong CP, Phillips WA, Clemons NJ. Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis. Oncotarget 2016;7:83342-58. [PMID: 27863424 DOI: 10.18632/oncotarget.13391] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
438 Teoh AY, Chiu PW, Yeung WK, Liu SY, Wong SK, Ng EK. Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial. Ann Oncol 2013;24:165-71. [PMID: 22887465 DOI: 10.1093/annonc/mds206] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
439 Donohoe CL, Mcgillycuddy E, Reynolds JV. Long-Term Health-Related Quality of Life for Disease-Free Esophageal Cancer Patients. World J Surg 2011;35:1853-60. [DOI: 10.1007/s00268-011-1123-6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
440 Helminen O, Mrena J, Sihvo E. Can We Increase the Resection Rate by Minimally Invasive Approach? Experience from 100 Minimally Invasive Esophagectomies. J Oncol 2019;2019:3809383. [PMID: 30915119 DOI: 10.1155/2019/3809383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
441 Kosumi K, Baba Y, Yamashita K, Ishimoto T, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Harada K, Shigaki H, Kurashige J, Iwatsuki M, Sakamoto Y, Yoshida N, Watanabe M, Baba H. Monitoring sputum culture in resected esophageal cancer patients with preoperative treatment. Diseases of the Esophagus 2017;30:1-9. [DOI: 10.1093/dote/dox092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
442 Zhao K, Wang C, Mao Q, Shang D, Huang Y, Ma L, Yu J, Li M. The flow-metabolism ratio might predict treatment response and survival in patients with locally advanced esophageal squamous cell carcinoma. EJNMMI Res 2020;10:57. [PMID: 32472227 DOI: 10.1186/s13550-020-00647-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
443 Belmouhand M, Löfgren J, Johannesen HH, Baeksgaard L, Gutte H, Tariq K, Achiam MP. Early response evaluation of neoadjuvant therapy with PET/MRI to predict resectability in patients with adenocarcinoma of the esophagogastric junction. Abdom Radiol (NY) 2019;44:836-44. [PMID: 30467723 DOI: 10.1007/s00261-018-1841-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
444 Yang M, Zhang H, Ma Z, Gong L, Chen C, Ren P, Shang X, Tang P, Jiang H, Yu Z. Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection. J Thorac Dis. 2017;9:1182-1189. [PMID: 28616267 DOI: 10.21037/jtd.2017.03.187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
445 Howard JM, Johnston C. Patterns of lymphatic drainage and lymph node involvement in esophageal cancer. Abdom Imaging 2013;38:233-43. [PMID: 22711183 DOI: 10.1007/s00261-012-9914-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
446 Hu Y, Puri V, Shami VM, Stukenborg GJ, Kozower BD. Comparative Effectiveness of Esophagectomy Versus Endoscopic Treatment for Esophageal High-grade Dysplasia. Ann Surg. 2016;263:719-726. [PMID: 26672723 DOI: 10.1097/sla.0000000000001387] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
447 Li C, Yamashita DT, Hawel JD, Bethune D, Henteleff H, Ellsmere J. Endoscopic mucosal resection versus esophagectomy for intramucosal adenocarcinoma in the setting of barrett's esophagus. Surg Endosc 2017;31:4211-6. [PMID: 28342132 DOI: 10.1007/s00464-017-5479-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
448 Wani S, Wallace MB, Cohen J, Pike IM, Adler DG, Kochman ML, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Tokar JL. Quality indicators for EUS. Gastrointest Endosc. 2015;81:67-80. [PMID: 25480097 DOI: 10.1016/j.gie.2014.07.054] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
449 Alline M, Bertrand MM, Colombo PE, Mourregot A, Rouanet P. [Lymph node dissection: what for? From esophagus to rectum: surgical and lymph node related prognostic factors]. Bull Cancer. 2014;101:368-372. [PMID: 24793629 DOI: 10.1684/bdc.2014.1929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
450 Liu X, Hu Y, Li K, Wang Y, Jiang Y, Guo W. Intraoperative conversion does not affect the oncological outcomes of minimally invasive esophagectomy for treatment of esophageal cancer. Surg Endosc 2018;32:4517-26. [DOI: 10.1007/s00464-018-6202-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
451 Li F, Zhu D, Yang Y, Wu K, Zhao S. Overexpression of calcyphosine is associated with poor prognosis in esophageal squamous cell carcinoma. Oncol Lett 2017;14:6231-7. [PMID: 29113272 DOI: 10.3892/ol.2017.6973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
452 McLaren PJ, Dolan JP. Surgical Treatment of High-Grade Dysplasia and Early Esophageal Cancer. World J Surg 2017;41:1712-8. [PMID: 28258451 DOI: 10.1007/s00268-017-3958-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
453 Irie T, Matsutani T, Hagiwara N, Ohashi R, Nomura T, Hanawa H, Mishima K, Taniai N, Yoshida H. Sarcoid-like reaction in lymphadenopathy associated with superficial esophageal squamous cell carcinoma. Clin J Gastroenterol 2020;13:688-92. [PMID: 32519313 DOI: 10.1007/s12328-020-01156-x] [Reference Citation Analysis]
454 Leng XF, Zhu Y, Wang GP, Jin J, Xian L, Zhang YH. Accuracy of ultrasound for the diagnosis of cervical lymph node metastasis in esophageal cancer: a systematic review and meta-analysis. J Thorac Dis 2016;8:2146-57. [PMID: 27621871 DOI: 10.21037/jtd.2016.07.71] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
455 Wang ZL, Chen Y, Li XT, Chen KN, Sun YS. Potential of Baseline Computed Tomography to Predict Long-Term Survival of Patients With Locally Advanced Esophageal Cancer Treated With Preoperative Chemotherapy: A Retrospective Cohort Study. Medicine (Baltimore) 2016;95:e3583. [PMID: 27149488 DOI: 10.1097/MD.0000000000003583] [Reference Citation Analysis]
456 Toxopeus EL, Talman S, van der Gaast A, Spaander VM, van Rij CM, Krak NC, Biermann K, Tilanus HW, Mathijssen RH, van Lanschot JJ, Wijnhoven BP. Induction chemotherapy followed by surgery for advanced oesophageal cancer. Eur J Surg Oncol 2015;41:323-32. [PMID: 25534280 DOI: 10.1016/j.ejso.2014.11.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
457 Huang X, Liu C, Cui Y, Zhang H, Liu Y, Zhou X, Luo J. Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma. Oncol Lett. 2017;13:704-714. [PMID: 28356949 DOI: 10.3892/ol.2016.5496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
458 Wang C, Cheng JC, Tsai C, Lee J, Huang P, Lin C, Hsu C, Hsieh M, Chang Y, Hsu F. Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma. Radiotherapy and Oncology 2015;115:9-15. [DOI: 10.1016/j.radonc.2015.03.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
459 Wittekind C. The development of the TNM classification of gastric cancer. Pathol Int. 2015;65:399-403. [PMID: 26036980 DOI: 10.1111/pin.12306] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
460 Oshikiri T, Yamamoto Y, Miki I, Tsuda M, Nakamura T, Fujino Y, Tominaga M, Kakeji Y. Conservative reconstruction using stents as salvage therapy for disruption of esophago-gastric anastomosis. World J Gastroenterol 2015; 21(28): 8723-8729 [PMID: 26229414 DOI: 10.3748/wjg.v21.i28.8723] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
461 Xu Y, Hong C, Wu Z, Peng Y, Ran L, Yang S, Huang B, Liang X, Chen H, Wu J, Xu X, Deng J, Zou H, Fang W, Li E, Xu L, Xie J. Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma. Clinics and Research in Hepatology and Gastroenterology 2018;42:597-603. [DOI: 10.1016/j.clinre.2018.08.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
462 Shiraishi O, Yasuda T, Kato H, Iwama M, Hiraki Y, Yasuda A, Shinkai M, Kimura Y, Imano M. Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer. Ann Surg Oncol 2020;27:4433-40. [PMID: 32409967 DOI: 10.1245/s10434-020-08579-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
463 Kim SY, Park S, Park IK, Kim YT, Kang CH. Lymph Node Status after Neoadjuvant Chemoradiation Therapy for Esophageal Cancer according to Radiation Field Coverage. Korean J Thorac Cardiovasc Surg 2019;52:353-9. [PMID: 31624713 DOI: 10.5090/kjtcs.2019.52.5.353] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
464 Kosumi K, Baba Y, Sakamoto A, Ishimoto T, Harada K, Nakamura K, Kurashige J, Hiyoshi Y, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Hino S, Nakao M, Baba H. Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer. Int J Cancer 2016;138:428-39. [PMID: 26240060 DOI: 10.1002/ijc.29714] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
465 Watson TJ. Esophagectomy for Superficial Esophageal Neoplasia. Gastrointest Endosc Clin N Am 2017;27:531-46. [PMID: 28577773 DOI: 10.1016/j.giec.2017.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
466 Rietveld SCM, Witvliet-van Nierop JE, Ottens-oussoren K, van der Peet DL, de van der Schueren MAE. The Prediction of Deterioration of Nutritional Status during Chemoradiation Therapy in Patients with Esophageal Cancer. Nutrition and Cancer 2018;70:229-35. [DOI: 10.1080/01635581.2018.1412481] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
467 Kudo T, Oshikiri T, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y. Three-dimensional visualization system is one of the factors that improve short-term outcomes after minimally invasive esophagectomy. Langenbecks Arch Surg 2021;406:631-9. [PMID: 33196872 DOI: 10.1007/s00423-020-02028-1] [Reference Citation Analysis]
468 Choi Y, Choi JY, Hong TH, Choi YL, Oh D, Woo SY, Shim YM, Zo JI, Kim HK, Lee KS. Trimodality therapy for locally advanced esophageal squamous cell carcinoma: the role of volume-based PET/CT in patient management and prognostication. Eur J Nucl Med Mol Imaging 2021. [PMID: 34365522 DOI: 10.1007/s00259-021-05487-w] [Reference Citation Analysis]
469 Berry MF. Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis. 2014;6 Suppl 3:S289-S297. [PMID: 24876933 DOI: 10.3978/j.issn.2072-1439.2014.03.11] [Cited by in F6Publishing: 57] [Reference Citation Analysis]
470 Liu W, He JZ, Wang SH, Liu DK, Bai XF, Xu XE, Wu JY, Jiang Y, Li CQ, Chen LQ, Li EM, Xu LY. MASAN: a novel staging system for prognosis of patients with oesophageal squamous cell carcinoma. Br J Cancer 2018;118:1476-84. [PMID: 29765149 DOI: 10.1038/s41416-018-0094-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
471 Wu SG, Li FY, Zhou J, Lin Q, Sun JY, Lin HX, Guan XX, He ZY. Prognostic value of different lymph node staging methods in esophageal squamous cell carcinoma after esophagectomy. Ann Thorac Surg 2015;99:284-90. [PMID: 25440270 DOI: 10.1016/j.athoracsur.2014.08.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
472 Oshikiri T, Yasuda T, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Sumi Y, Nakamura T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y. Trainee competence in thoracoscopic esophagectomy in the prone position: evaluation using cumulative sum techniques. Langenbecks Arch Surg 2016;401:797-804. [DOI: 10.1007/s00423-016-1484-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
473 Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Komohara Y, Baba H. IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer. Annals of Surgery 2019;269:1101-8. [DOI: 10.1097/sla.0000000000002754] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
474 Ashraf N, Hoffe S, Kim R. Locally advanced gastroesophageal junction tumor: a treatment dilemma. Oncologist 2015;20:134-42. [PMID: 25561508 DOI: 10.1634/theoncologist.2014-0377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
475 Duan H, Zhang X, Wang FX, Cai MY, Ma GW, Yang H, Fu JH, Tan ZH, Fu XY, Ma QL, Wang XY, Lin P. KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients. Oncotarget 2016;7:80493-507. [PMID: 27563815 DOI: 10.18632/oncotarget.11492] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
476 Park SY, Yoon JK, Lee SJ, Haam S, Jung J. Postoperative change of the psoas muscle area as a predictor of survival in surgically treated esophageal cancer patients. J Thorac Dis 2017;9:355-61. [PMID: 28275484 DOI: 10.21037/jtd.2017.02.42] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
477 Kosumi K, Yoshida N, Okadome K, Eto T, Kuroda D, Ohuchi M, Kiyozumi Y, Nakamura K, Izumi D, Tokunaga R, Harada K, Mima K, Sawayama H, Ishimoto T, Iwatsuki M, Baba Y, Miyamoto Y, Watanabe M, Baba H. Minimally invasive esophagectomy may contribute to long-term respiratory function after esophagectomy for esophageal cancer. Diseases of the Esophagus 2018;31. [DOI: 10.1093/dote/dox153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
478 Kosumi K, Baba Y, Okadome K, Yagi T, Kiyozumi Y, Yoshida N, Watanabe M, Baba H. Tumor Long-interspersed Nucleotide Element-1 Methylation Level and Immune Response to Esophageal Cancer. Annals of Surgery 2020;272:1025-34. [DOI: 10.1097/sla.0000000000003264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
479 Findlay JM, Tilson RC, Harikrishnan A, Sgromo B, Marshall REK, Maynard ND, Gillies RS, Middleton MR. Attempted validation of the NUn score and inflammatory markers as predictors of esophageal anastomotic leak and major complications: Attempted validation of the NUn score. Dis Esophagus 2015;28:626-33. [DOI: 10.1111/dote.12244] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
480 Sato H, Inoue H, Kobayashi Y, Maselli R, Santi EG, Hayee B, Igarashi K, Yoshida A, Ikeda H, Onimaru M. Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc. 2013;78:250-257. [PMID: 23453294 DOI: 10.1016/j.gie.2013.01.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
481 Li H, Zhen H, Han L, Yan B, Yu J, Zhu S, Cao B. Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population. Tumour Biol 2015;36:3985-93. [PMID: 25577251 DOI: 10.1007/s13277-015-3042-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
482 Tekola BD, Sauer BG, Wang AY, White GE, Shami VM. Accuracy of endoscopic ultrasound in the diagnosis of T2N0 esophageal cancer. J Gastrointest Cancer. 2014;45:342-346. [PMID: 24788081 DOI: 10.1007/s12029-014-9616-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
483 Cooper L, Dezube AR, De León LE, Kucukak S, Mazzola E, Dumontier C, Mamon H, Enzinger P, Jaklitsch MT, Frain LN, Wee JO. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer. Eur J Surg Oncol 2021:S0748-7983(21)00418-2. [PMID: 33895020 DOI: 10.1016/j.ejso.2021.04.013] [Reference Citation Analysis]
484 Li Q, Tanaka Y, Miwa N. Influence of hydrogen-occluding-silica on migration and apoptosis in human esophageal cells in vitro. Med Gas Res 2017;7:76-85. [PMID: 28744359 DOI: 10.4103/2045-9912.208510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
485 Tustumi F, Kimura CM, Takeda FR, Uema RH, Salum RA, Ribeiro-Junior U, Cecconello I. PROGNOSTIC FACTORS AND SURVIVAL ANALYSIS IN ESOPHAGEAL CARCINOMA. Arq Bras Cir Dig 2016;29:138-41. [PMID: 27759773 DOI: 10.1590/0102-6720201600030003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
486 Li L, Zhao L, Lin B, Su H, Su M, Xie D, Jin X, Xie C. Adjuvant Therapeutic Modalities Following Three-field Lymph Node Dissection for Stage II/III Esophageal Squamous Cell Carcinoma. J Cancer 2017;8:2051-9. [PMID: 28819406 DOI: 10.7150/jca.18981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
487 Mclaren PJ, Dolan JP. Esophagectomy as a Treatment Consideration for Early-Stage Esophageal Cancer and High-Grade Dysplasia. Journal of Laparoendoscopic & Advanced Surgical Techniques 2016;26:757-62. [DOI: 10.1089/lap.2016.29010.pjm] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
488 Barbetta A, Faraz S, Shah P, Gerdes H, Hsu M, Tan KS, Nobel T, Bains MS, Bott M, Isbell JM, Sewell DB, Jones DR, Molena D. Quality of Endoscopy Reports for Esophageal Cancer Patients: Where Do We Stand? J Gastrointest Surg 2018;22:778-84. [PMID: 29508217 DOI: 10.1007/s11605-018-3710-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
489 Davies AR, Sandhu H, Pillai A, Sinha P, Mattsson F, Forshaw MJ, Gossage JA, Lagergren J, Allum WH, Mason RC. Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancer. Br J Surg. 2014;101:511-517. [PMID: 24615656 DOI: 10.1002/bjs.9456] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
490 Lei Z, Tian D, Zhang C, Zhao S, Su M. Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma. BMC Cancer 2016;16:410. [PMID: 27388201 DOI: 10.1186/s12885-016-2462-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
491 DaVee T, Ajani JA, Lee JH. Is endoscopic ultrasound examination necessary in the management of esophageal cancer? World J Gastroenterol 2017; 23(5): 751-762 [PMID: 28223720 DOI: 10.3748/wjg.v23.i5.751] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
492 Zhuo ZG, Li G, Song TN, Alai GH, Shen X, Wang Y, Lin YD. From McKeown to Ivor Lewis, the learning curve for thoracic lymphadenectomy over the first 100 robotic esophagectomy cases: a retrospective study. J Thorac Dis 2021;13:1543-52. [PMID: 33841946 DOI: 10.21037/jtd-20-2862] [Reference Citation Analysis]
493 Kaneko Y, Hisakura K, Ogawa K, Akashi Y, Ohara Y, Owada Y, Enomoto T, Furuya K, Moue S, Doi M, Takahashi K, Shimomura O, Hashimoto S, Sakamoto N, Maruyama T, Oda T. Long-term survival after esophagectomy with distal pancreatectomy for locally advanced esophageal cancer with pancreatic invasion: a case report. Surg Case Rep 2021;7:254. [PMID: 34905130 DOI: 10.1186/s40792-021-01338-w] [Reference Citation Analysis]
494 Anderegg MC, de Groof EJ, Gisbertz SS, Bennink RJ, Lagarde SM, Klinkenbijl JH, Dijkgraaf MG, Bergman JJ, Hulshof MC, van Laarhoven HW, van Berge Henegouwen MI. 18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making. PLoS One 2015;10:e0133690. [PMID: 26529313 DOI: 10.1371/journal.pone.0133690] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
495 Liu H, Lu L, Zhu Q, Hao Y, Mo Y, Liu M, Hu Y, Cui N, Rong T. Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after concurrent chemoradiotherapy. Radiother Oncol 2011;99:181-6. [PMID: 21620504 DOI: 10.1016/j.radonc.2011.05.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
496 Zanoni A, Verlato G, Giacopuzzi S, Motton M, Casella F, Weindelmayer J, Ambrosi E, Di Leo A, Vassiliadis A, Ricci F, Rice TW, de Manzoni G. ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer. Ann Surg Oncol 2016;23:998-1004. [PMID: 27480358 DOI: 10.1245/s10434-016-5440-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
497 Lohse I, Al-Ali H, Volmar CH, D Alvarez Trotta A, Brothers SP, Capobianco AJ, Wahlestedt C. Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma. PLoS One 2018;13:e0203173. [PMID: 30212533 DOI: 10.1371/journal.pone.0203173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
498 Wang Y, Shi J, Du L, Huang H, Wang L, Zhu J, Li H, Bai Y, Liao X, Mao A, Liu G, Ren J, Sun X, Gong J, Zhou Q, Mai L, Zhu L, Xing X, Liu Y, Ren Y, Song B, Lan L, Zhou J, Lou P, Sun X, Qi X, Wu S, Wei W, Zhang K, Dai M, Chen W, He J. Health-related quality of life in patients with esophageal cancer or precancerous lesions assessed by EQ-5D: A multicenter cross-sectional study. Thorac Cancer 2020;11:1076-89. [PMID: 32130756 DOI: 10.1111/1759-7714.13368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
499 O' Sullivan KE, Michielsen AJ, O' Regan E, Cathcart MC, Moore G, Breen E, Segurado R, Reynolds JV, Lysaght J, O' Sullivan J. pSTAT3 Levels Have Divergent Expression Patterns and Associations with Survival in Squamous Cell Carcinoma and Adenocarcinoma of the Oesophagus. Int J Mol Sci 2018;19:E1720. [PMID: 29890775 DOI: 10.3390/ijms19061720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
500 Zheng Y, Li Y, Liu X, Zhang R, Wang Z, Sun H, Liu S. Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma: a retrospective study. J Cancer 2019;10:1097-102. [PMID: 30854116 DOI: 10.7150/jca.29353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
501 Konieczny A, Meyer P, Schnider A, Komminoth P, Schmid M, Lombriser N, Weishaupt D. Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer. Eur Radiol. 2013;23:2492-2502. [PMID: 23645329 DOI: 10.1007/s00330-013-2844-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
502 Iwagami S, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Sakamaki K, Ohashi Y, Baba H. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Ann Surg. 2013;257:449-455. [PMID: 23023202 DOI: 10.1097/sla.0b013e31826d8602] [Cited by in Crossref: 75] [Cited by in F6Publishing: 41] [Article Influence: 8.3] [Reference Citation Analysis]
503 He Z, Wu S, Li Q, Lin Q, Xu J. Use of the metastatic lymph node ratio to evaluate the prognosis of esophageal cancer patients with node metastasis following radical esophagectomy. PLoS One. 2013;8:e73446. [PMID: 24039944 DOI: 10.1371/journal.pone.0073446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
504 Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location. The Annals of Thoracic Surgery 2016;101:1075-81. [DOI: 10.1016/j.athoracsur.2015.09.063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
505 Bonavina L, Scolari F, Aiolfi A, Bonitta G, Sironi A, Saino G, Asti E. Early outcome of thoracoscopic and hybrid esophagectomy: Propensity-matched comparative analysis. Surgery 2016;159:1073-81. [PMID: 26422764 DOI: 10.1016/j.surg.2015.08.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
506 Gunturu KS, Woo Y, Beaubier N, Remotti HE, Saif MW. Gastric cancer and trastuzumab: first biologic therapy in gastric cancer. Ther Adv Med Oncol. 2013;5:143-151. [PMID: 23450234 DOI: 10.1177/1758834012469429] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 5.2] [Reference Citation Analysis]
507 Dolan JP, Kaur T, Diggs BS, Luna RA, Sheppard BC, Schipper PH, Tieu BH, Bakis G, Vaccaro GM, Holland JM, Gatter KM, Conroy MA, Thomas CA, Hunter JG. Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy: Clinical staging in T2N0 esophageal cancer. Dis Esophagus 2016;29:320-5. [DOI: 10.1111/dote.12334] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
508 Tao H, Li F, Wang J, Dong W, Gao J, Jiao S, Hu Y. Management of treatment-naïve limited-stage small cell esophagus carcinoma. Saudi Med J 2015;36:297-303. [PMID: 25737171 DOI: 10.15537/smj.2015.3.11368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
509 Vollenbrock SE, Voncken FEM, van Dieren JM, Lambregts DMJ, Maas M, Meijer GJ, Goense L, Mook S, Hartemink KJ, Snaebjornsson P, Ter Beek LC, Verheij M, Aleman BMP, Beets-Tan RGH, Bartels-Rutten A. Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer. Br J Surg 2019;106:596-605. [PMID: 30802305 DOI: 10.1002/bjs.11094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
510 Ge L, Chen W, Cao W, Liu G, Zhang Q, Zhuang J, Zhang M, Yang J, Guo S, Zhao X, Guo H. GCN2 is a potential prognostic biomarker for human papillary renal cell carcinoma. CBM 2018;22:395-403. [DOI: 10.3233/cbm-170922] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
511 Xu J, Cao J, Wang L, Wang Z, Wang Y, Wu Y, Lv W, Hu J. Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction. Sci Rep. 2017;7:10123. [PMID: 28860457 DOI: 10.1038/s41598-017-09625-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
512 Kroese TE, Dijksterhuis WPM, van Rossum PSN, Verhoeven RHA, Mook S, Haj Mohammad N, Hulshof MCCM, van Berge Henegouwen MI, van Oijen MGH, Ruurda JP, van Laarhoven HWM, van Hillegersberg R. Prognosis of Interval Distant Metastases After Neoadjuvant Chemoradiotherapy for Esophageal Cancer. Ann Thorac Surg 2021:S0003-4975(21)00306-4. [PMID: 33610543 DOI: 10.1016/j.athoracsur.2021.01.061] [Reference Citation Analysis]
513 Koemans WJ, Larue RTHM, Kloft M, Ruisch JE, Compter I, Riedl RG, Heij LR, van Elmpt W, Berbée M, Buijsen J, Lambin P, Sosef MN, Grabsch HI. Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fields. Esophagus 2021;18:100-10. [PMID: 32889674 DOI: 10.1007/s10388-020-00777-y] [Reference Citation Analysis]
514 Tsai C, Yeh C, Chao Y, Chang H, Tseng C, Liu Y. Perineural invasion through the sheath in posttherapy esophagectomy specimens predicts poor survival in patients with esophageal squamous cell carcinoma. European Journal of Surgical Oncology (EJSO) 2017;43:1970-6. [DOI: 10.1016/j.ejso.2017.07.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
515 Machiels M, Jin P, van Gurp CH, van Hooft JE, Alderliesten T, Hulshof MCCM. Comparison of carina-based versus bony anatomy-based registration for setup verification in esophageal cancer radiotherapy. Radiat Oncol 2018;13:48. [PMID: 29562919 DOI: 10.1186/s13014-018-0986-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
516 Goense L, van Rossum PS, Kandioler D, Ruurda JP, Goh KL, Luyer MD, Krasna MJ, van Hillegersberg R. Stage-directed individualized therapy in esophageal cancer. Ann N Y Acad Sci 2016;1381:50-65. [PMID: 27384385 DOI: 10.1111/nyas.13113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
517 Sugawara K, Yoshimura S, Yagi K, Nishida M, Aikou S, Yamagata Y, Mori K, Yamashita H, Seto Y. Long-term health-related quality of life following robot-assisted radical transmediastinal esophagectomy. Surg Endosc 2020;34:1602-11. [DOI: 10.1007/s00464-019-06923-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
518 Dong J, Li W, Dong A, Mao S, Shen L, Li S, Gong X, Wu P. Gene therapy for unresectable hepatocellular carcinoma using recombinant human adenovirus type 5. Med Oncol. 2014;31:95. [PMID: 24990099 DOI: 10.1007/s12032-014-0095-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
519 Zhou Z, Xie X, Hao N, Diao D, Song Y, Xia P, Dang C, Zhang H. Different lymph node staging systems for patients with adenocarcinoma of esophagogastric junction. Curr Med Res Opin 2018;34:963-70. [PMID: 29338535 DOI: 10.1080/03007995.2018.1429390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
520 Cheng Y, Wang N, Wang K, Wang J, Tan B, Jia Y, Dou Y, Yu J. Prognostic value of body mass index for patients undergoing esophagectomy for esophageal squamous cell carcinoma. Jpn J Clin Oncol 2013;43:146-53. [PMID: 23264675 DOI: 10.1093/jjco/hys212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
521 Fountoulakis A, Souglakos J, Vini L, Douridas GN, Koumarianou A, Kountourakis P, Agalianos C, Alexandrou A, Dervenis C, Gourtsoyianni S, Gouvas N, Kalogeridi M, Levidou G, Liakakos T, Sgouros J, Sgouros SN, Triantopoulou C, Xynos E. Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer. Updates Surg 2019;71:599-624. [DOI: 10.1007/s13304-019-00696-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
522 Bekki Y, Kimura Y, Morita M, Zaitsu Y, Saeki H, Okamoto T, Oki E, Baba S, Oda Y, Maehara Y. Esophageal cancer associated with bilateral hilar lymphadenopathy caused by sarcoid-like reactions: a report of two cases. Esophagus 2015;12:322-6. [DOI: 10.1007/s10388-014-0454-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
523 Go S, Lee WS, Kang MH, Song H, Kim MJ, Lee MJ, Kim H, Lee GW, Kang JH, Lee J, Kang KM, Jeon K, Cho JM, Jung WT, Ko GH. Response to Concurrent Chemoradiotherapy as a Prognostic Marker in Elderly Patients with Locally Advanced Esophageal Cancer. Tumori 2012;98:225-32. [DOI: 10.1177/030089161209800208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
524 Zhang D, Zheng Y, Wang Z, Huang Q, Cao X, Wang F, Liu S. Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery. Eur J Surg Oncol. 2017;43:1949-1955. [PMID: 28716377 DOI: 10.1016/j.ejso.2017.06.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
525 Zhang X, Yan W, Sun Y, Li X, Chen Y, Fan M, Wu Y, Liang Z, Xiong H, Wang Z, Sun Y, Chen K. CT Signs Can Predict Treatment Response and Long-Term Survival: A Study in Locally Advanced Esophageal Cancer with Preoperative Chemotherapy. Ann Surg Oncol 2015;22:1380-7. [DOI: 10.1245/s10434-015-4531-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
526 Westerman ME, Sharma V, Bailey GC, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy. Int Braz J Urol 2019;45:468-77. [PMID: 30676305 DOI: 10.1590/S1677-5538.IBJU.2018.0196] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
527 Old OJ, Isabelle M, Barr H. Staging Early Esophageal Cancer. Adv Exp Med Biol 2016;908:161-81. [PMID: 27573772 DOI: 10.1007/978-3-319-41388-4_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
528 Shigaki H, Baba Y, Watanabe M, Miyake K, Murata A, Iwagami S, Ishimoto T, Iwatsuki M, Yoshida N, Baba H. KRAS and BRAF mutations in 203 esophageal squamous cell carcinomas: pyrosequencing technology and literature review. Ann Surg Oncol 2013;20 Suppl 3:S485-91. [PMID: 23274581 DOI: 10.1245/s10434-012-2819-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
529 Kanamori J, Watanabe M, Kozuki R, Toihata T, Otake R, Takahashi K, Okamura A, Imamura Y, Mine S. Successful transition from open to minimally invasive approach in Ivor Lewis esophagectomy: a single-center experience in Japan. Langenbecks Arch Surg 2021;406:1407-14. [PMID: 33721088 DOI: 10.1007/s00423-021-02150-8] [Reference Citation Analysis]
530 Shiraishi O, Yasuda T, Kato H, Momose K, Hiraki Y, Yasuda A, Shinkai M, Kimura Y, Imano M. Comparison of Aggressive Planned Salvage Surgery Versus Neoadjuvant Chemoradiotherapy Plus Surgery for Borderline Resectable T4 Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 33768398 DOI: 10.1245/s10434-021-09875-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
531 Li KK, Wang YJ, Liu XH, Tan QY, Jiang YG, Guo W. The effect of postoperative complications on survival of patients after minimally invasive esophagectomy for esophageal cancer. Surg Endosc 2017;31:3475-82. [PMID: 27924395 DOI: 10.1007/s00464-016-5372-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
532 Liu J, Cai X, Liu Q, Li H, Cheng Y, Fu X. Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer. Thorac Cancer. 2017;8:630-633. [PMID: 28941320 DOI: 10.1111/1759-7714.12499] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
533 Frankel A, Nancarrow D, Wayte N, Barbour A. Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key? ANZ J Surg 2012;82:599-606. [PMID: 22856687 DOI: 10.1111/j.1445-2197.2012.06144.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
534 Borggreve AS, Goense L, van Rossum PSN, Heethuis SE, van Hillegersberg R, Lagendijk JJW, Lam MGEH, van Lier ALHMW, Mook S, Ruurda JP, van Vulpen M, Voncken FEM, Aleman BMP, Bartels-Rutten A, Ma J, Fang P, Musall BC, Lin SH, Meijer GJ. Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using 18F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study. Int J Radiat Oncol Biol Phys 2020;106:998-1009. [PMID: 31987972 DOI: 10.1016/j.ijrobp.2019.12.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
535 Aubert E, Servois V. [Lymph nodes of esophagus cancer: radiological approach]. Cancer Radiother 2014;18:553-8. [PMID: 25205427 DOI: 10.1016/j.canrad.2014.06.019] [Reference Citation Analysis]
536 Wang B, Wu S, Chen H, Hung W, Lin C, Huang C, Chen H. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma. British Journal of Surgery 2019;106:255-62. [DOI: 10.1002/bjs.11004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
537 Kayani B, Zacharakis E, Ahmed K, Hanna GB. Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review. Eur J Surg Oncol 2011;37:747-53. [PMID: 21839394 DOI: 10.1016/j.ejso.2011.06.018] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
538 Davies AR, Myoteri D, Zylstra J, Baker CR, Wulaningsih W, Van Hemelrijck M, Maisey N, Allum WH, Smyth E, Gossage JA, Lagergren J, Cunningham D, Green M; Guy's and St Thomas' Oesophago-Gastric Research Group and PROGRESS Study Group. Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma. Br J Surg 2018;105:1639-49. [PMID: 30047556 DOI: 10.1002/bjs.10900] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
539 Allan BJ, Pedroso F, Gennis ER, Livingstone AS, Montero A, Lally B, Ardalan B, Koniaris LG, Solomon NL, Franceschi D. Influence of Treatment Modality in Outcomes for Different Stages of Resectable Esophageal Adenocarcinomas. Ann Surg Oncol 2013;20:1660-7. [DOI: 10.1245/s10434-012-2766-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
540 Nobel T, Molena D. Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma. Ann Gastroenterol Surg 2019;3:390-5. [PMID: 31346578 DOI: 10.1002/ags3.12268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
541 Sasaki Y, Shimizu H, Nemoto T, Urita Y. Cancer-associated myositis associated with oesophageal adenocarcinoma arising in Barrett's oesophagus without serum myogenic enzymes elevation: an example suggesting the importance of MRI. BMJ Case Rep 2016;2016:bcr2016215047. [PMID: 27102418 DOI: 10.1136/bcr-2016-215047] [Reference Citation Analysis]
542 Wu J, Chen QX. Prognostic and predictive significance of tumor length in patients with esophageal squamous cell carcinoma undergoing radical resection. BMC Cancer 2016;16:394. [PMID: 27387460 DOI: 10.1186/s12885-016-2417-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
543 Li HE, Wang X, Tang Z, Liu F, Chen W, Fang Y, Wang C, Shen K, Qin J, Shen Z, Sun Y, Qin X. A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients. Oncol Lett 2015;10:2107-17. [PMID: 26622804 DOI: 10.3892/ol.2015.3609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
544 Allen CJ, DiPasco PJ, Koshenkov V, Franceschi D. Non-Hodgkin's Lymphoma as a Risk Factor for Persistent Chylothorax After Transhiatal Esophagectomy. World J Oncol 2012;3:233-5. [PMID: 29147312 DOI: 10.4021/wjon523w] [Reference Citation Analysis]
545 Yang Y, Jia J, Sun Z, Liu C, Li Z, Xiao Y, Yu J, Du F, Shi Y, Sun J, Shui J, Zhang X. Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma. Future Oncol 2021;17:2351-63. [PMID: 33709789 DOI: 10.2217/fon-2020-1191] [Reference Citation Analysis]
546 Lai S, Su T, He X, Lin Z, Chen S. Prognostic value of resected lymph nodes numbers for Siewert II gastroesophageal junction cancer. Oncotarget 2018;9:2797-809. [PMID: 29416812 DOI: 10.18632/oncotarget.23540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
547 Kitano Y, Baba Y, Nakagawa S, Miyake K, Iwatsuki M, Ishimoto T, Yamashita YI, Yoshida N, Watanabe M, Nakao M, Baba H. Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species. J Pathol 2018;244:346-57. [PMID: 29243822 DOI: 10.1002/path.5021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
548 Kim JW, Lee H, Min YW, Min BH, Lee JH, Sohn TS, Kim JJ, Kim S. Oncologic Safety of Endoscopic Resection Based on Lymph Node Metastasis in Ulcerative Early Gastric Cancer. J Laparoendosc Adv Surg Tech A 2019;29:1105-10. [PMID: 31334672 DOI: 10.1089/lap.2019.0311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
549 Al Natour RH, Catanzaro A, Zolotarevsky E, Debenedet AT, Gunaratnam NT. Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach. Diseases of the Esophagus 2017;31. [DOI: 10.1093/dote/dox126] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
550 Lin CH, Hung TM, Chang YC, Hsieh CH, Shih MC, Huang SM, Yang CK, Chang CF, Chan SC, Yap WK. Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy. Cancers (Basel) 2020;12:E607. [PMID: 32155748 DOI: 10.3390/cancers12030607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
551 Liao Y, Ma Z, Zhang Y, Li D, Lv D, Chen Z, Li P, Ai-Dherasi A, Zheng F, Tian J, Zou K, Wang Y, Wang D, Cordova M, Zhou H, Li X, Liu D, Yu R, Zhang Q, Zhang X, Zhang J, Zhang X, Zhang X, Li Y, Shao Y, Song L, Liu R, Wang Y, Sufiyan S, Liu Q, Owen GI, Li Z, Chen J. Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma. Cancer Med 2019;8:5673-86. [PMID: 31369215 DOI: 10.1002/cam4.2458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
552 Wada T, Takeuchi H, Kawakubo H, Nakamura R, Oyama T, Takahashi T, Wada N, Saikawa Y, Omori T, Jinzaki M, Kuribayashi S, Kitagawa Y. Clinical utility of preoperative evaluation of bronchial arteries by three-dimensional computed tomographic angiography for esophageal cancer surgery. Dis Esophagus 2013;26:616-22. [PMID: 23237474 DOI: 10.1111/dote.12012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
553 Yu Y, Ren KM. Development of a prognostic prediction model based on microRNA-1269a in esophageal cancer. World J Gastrointest Oncol 2021; 13(8): 943-958 [PMID: 34457197 DOI: 10.4251/wjgo.v13.i8.943] [Reference Citation Analysis]
554 Tustumi F, Takeda FR, Uema RH, Pereira GL, Sallum RA, Cecconello I. Primary neuroendocrine neoplasm of the esophagus - Report of 14 cases from a single institute and review of the literature. Arq Gastroenterol. 2017;54:4-10. [PMID: 28079231 DOI: 10.1590/s0004-2803.2017v54n1-01] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
555 Mei LX, Mo JX, Chen Y, Dai L, Wang YY, Chen MW. Esophagectomy versus definitive chemoradiotherapy as initial treatment for clinical stage I esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2021:doab049. [PMID: 34318324 DOI: 10.1093/dote/doab049] [Reference Citation Analysis]
556 Smit JK, Güler S, Beukema JC, Mul VE, Burgerhof JG, Hospers GA, Plukker JT. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients. Ann Surg Oncol 2013;20:4008-15. [PMID: 23838922 DOI: 10.1245/s10434-013-3102-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
557 Yi J, Pan BZ, Xiong L, Song HZ. Clinical significance of angiopoietin-like protein 4 expression in tissue and serum of esophageal squamous cell carcinoma patients. Med Oncol 2013;30:680. [PMID: 23925665 DOI: 10.1007/s12032-013-0680-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
558 Lou F, Sima CS, Adusumilli PS, Bains MS, Sarkaria IS, Rusch VW, Rizk NP. Esophageal cancer recurrence patterns and implications for surveillance. J Thorac Oncol 2013;8:1558-62. [PMID: 24389438 DOI: 10.1097/01.JTO.0000437420.38972.fb] [Cited by in Crossref: 75] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
559 Al-Batran SE, Lorenzen S. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge? Hematol Oncol Clin North Am 2017;31:441-52. [PMID: 28501086 DOI: 10.1016/j.hoc.2017.01.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]